CN104352983A - Health oral liquid for treatment of qi-stagnancy and blood stasis and preparation method thereof - Google Patents
Health oral liquid for treatment of qi-stagnancy and blood stasis and preparation method thereof Download PDFInfo
- Publication number
- CN104352983A CN104352983A CN201410665602.9A CN201410665602A CN104352983A CN 104352983 A CN104352983 A CN 104352983A CN 201410665602 A CN201410665602 A CN 201410665602A CN 104352983 A CN104352983 A CN 104352983A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- blood
- oral liquid
- blood stasis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000008280 blood Substances 0.000 title claims abstract description 216
- 210000004369 blood Anatomy 0.000 title claims abstract description 207
- 239000007788 liquid Substances 0.000 title claims abstract description 52
- 230000036541 health Effects 0.000 title claims abstract description 19
- 238000002360 preparation method Methods 0.000 title claims description 20
- 238000011282 treatment Methods 0.000 title abstract description 41
- 239000003814 drug Substances 0.000 claims abstract description 77
- 229940079593 drug Drugs 0.000 claims abstract description 32
- 239000002994 raw material Substances 0.000 claims abstract description 21
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 42
- 210000000582 semen Anatomy 0.000 claims description 23
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 23
- 210000003734 kidney Anatomy 0.000 claims description 22
- 239000010271 massa medicata fermentata Substances 0.000 claims description 20
- 238000010438 heat treatment Methods 0.000 claims description 19
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 18
- 241000628997 Flos Species 0.000 claims description 17
- 230000002829 reductive effect Effects 0.000 claims description 17
- 239000009636 Huang Qi Substances 0.000 claims description 15
- 239000000706 filtrate Substances 0.000 claims description 14
- 230000008901 benefit Effects 0.000 claims description 12
- 239000006228 supernatant Substances 0.000 claims description 12
- 238000000108 ultra-filtration Methods 0.000 claims description 12
- 238000000605 extraction Methods 0.000 claims description 11
- 229920001353 Dextrin Polymers 0.000 claims description 9
- 239000004375 Dextrin Substances 0.000 claims description 9
- 235000019425 dextrin Nutrition 0.000 claims description 9
- 239000000284 extract Substances 0.000 claims description 9
- 238000010992 reflux Methods 0.000 claims description 9
- 238000001914 filtration Methods 0.000 claims description 8
- 239000000843 powder Substances 0.000 claims description 8
- 238000005202 decontamination Methods 0.000 claims description 5
- 230000003588 decontaminative effect Effects 0.000 claims description 5
- 238000002481 ethanol extraction Methods 0.000 claims description 5
- 239000008187 granular material Substances 0.000 claims description 5
- 235000011837 pasties Nutrition 0.000 claims description 5
- 230000006837 decompression Effects 0.000 claims description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 3
- 238000004321 preservation Methods 0.000 claims description 3
- 230000001954 sterilising effect Effects 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- 239000002562 thickening agent Substances 0.000 claims description 3
- 230000000249 desinfective effect Effects 0.000 claims description 2
- 230000005855 radiation Effects 0.000 claims description 2
- 210000004185 liver Anatomy 0.000 abstract description 78
- 230000000694 effects Effects 0.000 abstract description 62
- 208000002193 Pain Diseases 0.000 abstract description 42
- 230000036407 pain Effects 0.000 abstract description 41
- 208000011580 syndromic disease Diseases 0.000 abstract description 31
- 208000005171 Dysmenorrhea Diseases 0.000 abstract description 24
- 230000017531 blood circulation Effects 0.000 abstract description 21
- 230000007812 deficiency Effects 0.000 abstract description 21
- 238000000034 method Methods 0.000 abstract description 20
- 210000001015 abdomen Anatomy 0.000 abstract description 19
- 208000024891 symptom Diseases 0.000 abstract description 16
- 208000019255 Menstrual disease Diseases 0.000 abstract description 13
- 230000005906 menstruation Effects 0.000 abstract description 12
- 208000004998 Abdominal Pain Diseases 0.000 abstract description 9
- 230000008569 process Effects 0.000 abstract description 8
- 238000010792 warming Methods 0.000 abstract description 6
- 206010016256 fatigue Diseases 0.000 abstract description 5
- 230000004069 differentiation Effects 0.000 abstract description 4
- 240000000031 Achyranthes bidentata Species 0.000 abstract 1
- 244000144730 Amygdalus persica Species 0.000 abstract 1
- 241000382455 Angelica sinensis Species 0.000 abstract 1
- 241000045403 Astragalus propinquus Species 0.000 abstract 1
- 235000014375 Curcuma Nutrition 0.000 abstract 1
- 244000164480 Curcuma aromatica Species 0.000 abstract 1
- 241001673966 Magnolia officinalis Species 0.000 abstract 1
- 241000218231 Moraceae Species 0.000 abstract 1
- 235000008708 Morus alba Nutrition 0.000 abstract 1
- 244000124853 Perilla frutescens Species 0.000 abstract 1
- 235000004348 Perilla frutescens Nutrition 0.000 abstract 1
- 241000208966 Polygala Species 0.000 abstract 1
- 241000037826 Polygonatum kingianum Species 0.000 abstract 1
- 244000197580 Poria cocos Species 0.000 abstract 1
- 235000008599 Poria cocos Nutrition 0.000 abstract 1
- 235000006040 Prunus persica var persica Nutrition 0.000 abstract 1
- 241000304195 Salvia miltiorrhiza Species 0.000 abstract 1
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 abstract 1
- 235000006533 astragalus Nutrition 0.000 abstract 1
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 abstract 1
- 230000009429 distress Effects 0.000 abstract 1
- 230000036512 infertility Effects 0.000 abstract 1
- 201000005630 leukorrhea Diseases 0.000 abstract 1
- 206010046901 vaginal discharge Diseases 0.000 abstract 1
- 201000010099 disease Diseases 0.000 description 30
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 30
- 239000007789 gas Substances 0.000 description 29
- 206010013935 Dysmenorrhoea Diseases 0.000 description 25
- 230000001737 promoting effect Effects 0.000 description 25
- 230000006870 function Effects 0.000 description 20
- 239000000463 material Substances 0.000 description 20
- 210000000952 spleen Anatomy 0.000 description 20
- 239000000243 solution Substances 0.000 description 17
- 206010011224 Cough Diseases 0.000 description 16
- 230000001105 regulatory effect Effects 0.000 description 16
- 210000000481 breast Anatomy 0.000 description 15
- 238000011160 research Methods 0.000 description 14
- 238000012360 testing method Methods 0.000 description 14
- 102100028452 Nitric oxide synthase, endothelial Human genes 0.000 description 13
- 101710090055 Nitric oxide synthase, endothelial Proteins 0.000 description 13
- 210000002784 stomach Anatomy 0.000 description 13
- 210000002216 heart Anatomy 0.000 description 12
- 201000000736 Amenorrhea Diseases 0.000 description 11
- 206010001928 Amenorrhoea Diseases 0.000 description 11
- 231100000540 amenorrhea Toxicity 0.000 description 11
- 235000005911 diet Nutrition 0.000 description 11
- 230000037213 diet Effects 0.000 description 11
- 235000013305 food Nutrition 0.000 description 11
- 206010037660 Pyrexia Diseases 0.000 description 10
- 241000700159 Rattus Species 0.000 description 10
- 230000008859 change Effects 0.000 description 10
- 230000004087 circulation Effects 0.000 description 10
- 230000008451 emotion Effects 0.000 description 10
- 230000007246 mechanism Effects 0.000 description 10
- 210000004914 menses Anatomy 0.000 description 10
- 230000001575 pathological effect Effects 0.000 description 10
- 210000001519 tissue Anatomy 0.000 description 10
- 206010010774 Constipation Diseases 0.000 description 9
- 206010012735 Diarrhoea Diseases 0.000 description 9
- 208000032843 Hemorrhage Diseases 0.000 description 9
- 241001465754 Metazoa Species 0.000 description 9
- 206010040007 Sense of oppression Diseases 0.000 description 9
- 235000009508 confectionery Nutrition 0.000 description 9
- 230000002440 hepatic effect Effects 0.000 description 9
- 206010062717 Increased upper airway secretion Diseases 0.000 description 8
- 208000004880 Polyuria Diseases 0.000 description 8
- 210000001124 body fluid Anatomy 0.000 description 8
- 239000010839 body fluid Substances 0.000 description 8
- 210000000038 chest Anatomy 0.000 description 8
- 230000001276 controlling effect Effects 0.000 description 8
- 230000035619 diuresis Effects 0.000 description 8
- 210000004072 lung Anatomy 0.000 description 8
- 208000026435 phlegm Diseases 0.000 description 8
- 238000005728 strengthening Methods 0.000 description 8
- 230000035922 thirst Effects 0.000 description 8
- 206010000087 Abdominal pain upper Diseases 0.000 description 7
- 208000031971 Yin Deficiency Diseases 0.000 description 7
- 230000009286 beneficial effect Effects 0.000 description 7
- 230000015572 biosynthetic process Effects 0.000 description 7
- 230000035568 catharsis Effects 0.000 description 7
- 239000006185 dispersion Substances 0.000 description 7
- 208000002173 dizziness Diseases 0.000 description 7
- 230000014509 gene expression Effects 0.000 description 7
- 230000033001 locomotion Effects 0.000 description 7
- 230000014759 maintenance of location Effects 0.000 description 7
- 210000003205 muscle Anatomy 0.000 description 7
- 230000001717 pathogenic effect Effects 0.000 description 7
- 208000006820 Arthralgia Diseases 0.000 description 6
- 230000037396 body weight Effects 0.000 description 6
- 206010061428 decreased appetite Diseases 0.000 description 6
- 210000003414 extremity Anatomy 0.000 description 6
- 230000002175 menstrual effect Effects 0.000 description 6
- 210000001835 viscera Anatomy 0.000 description 6
- 230000002087 whitening effect Effects 0.000 description 6
- 206010007247 Carbuncle Diseases 0.000 description 5
- 241000700199 Cavia porcellus Species 0.000 description 5
- 206010014080 Ecchymosis Diseases 0.000 description 5
- 206010019233 Headaches Diseases 0.000 description 5
- 208000009205 Tinnitus Diseases 0.000 description 5
- 206010047700 Vomiting Diseases 0.000 description 5
- 208000027418 Wounds and injury Diseases 0.000 description 5
- 208000019790 abdominal distention Diseases 0.000 description 5
- 239000003172 expectorant agent Substances 0.000 description 5
- 230000003419 expectorant effect Effects 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 231100000869 headache Toxicity 0.000 description 5
- 230000010354 integration Effects 0.000 description 5
- 210000002381 plasma Anatomy 0.000 description 5
- 238000010791 quenching Methods 0.000 description 5
- 238000003860 storage Methods 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 230000008961 swelling Effects 0.000 description 5
- 231100000886 tinnitus Toxicity 0.000 description 5
- 208000020401 Depressive disease Diseases 0.000 description 4
- 208000000059 Dyspnea Diseases 0.000 description 4
- 206010013975 Dyspnoeas Diseases 0.000 description 4
- 206010022998 Irritability Diseases 0.000 description 4
- 102100029438 Nitric oxide synthase, inducible Human genes 0.000 description 4
- 101710089543 Nitric oxide synthase, inducible Proteins 0.000 description 4
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 4
- 206010052428 Wound Diseases 0.000 description 4
- 238000009825 accumulation Methods 0.000 description 4
- 230000000844 anti-bacterial effect Effects 0.000 description 4
- 238000013459 approach Methods 0.000 description 4
- 208000006673 asthma Diseases 0.000 description 4
- 230000036772 blood pressure Effects 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 201000006549 dyspepsia Diseases 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 230000029142 excretion Effects 0.000 description 4
- 239000004744 fabric Substances 0.000 description 4
- 235000019197 fats Nutrition 0.000 description 4
- 206010022437 insomnia Diseases 0.000 description 4
- 230000003993 interaction Effects 0.000 description 4
- 230000009545 invasion Effects 0.000 description 4
- 230000007774 longterm Effects 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 230000003821 menstrual periods Effects 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 231100000862 numbness Toxicity 0.000 description 4
- 244000052769 pathogen Species 0.000 description 4
- 230000035790 physiological processes and functions Effects 0.000 description 4
- 229940124549 vasodilator Drugs 0.000 description 4
- 239000003071 vasodilator agent Substances 0.000 description 4
- MIJYXULNPSFWEK-GTOFXWBISA-N 3beta-hydroxyolean-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MIJYXULNPSFWEK-GTOFXWBISA-N 0.000 description 3
- 208000034656 Contusions Diseases 0.000 description 3
- JKLISIRFYWXLQG-UHFFFAOYSA-N Epioleonolsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4CCC3C21C JKLISIRFYWXLQG-UHFFFAOYSA-N 0.000 description 3
- 208000015220 Febrile disease Diseases 0.000 description 3
- 206010024453 Ligament sprain Diseases 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- YBRJHZPWOMJYKQ-UHFFFAOYSA-N Oleanolic acid Natural products CC1(C)CC2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C1)C(=O)O YBRJHZPWOMJYKQ-UHFFFAOYSA-N 0.000 description 3
- MIJYXULNPSFWEK-UHFFFAOYSA-N Oleanolinsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MIJYXULNPSFWEK-UHFFFAOYSA-N 0.000 description 3
- 206010033557 Palpitations Diseases 0.000 description 3
- 208000010040 Sprains and Strains Diseases 0.000 description 3
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 3
- 230000002159 abnormal effect Effects 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 238000010171 animal model Methods 0.000 description 3
- 208000022531 anorexia Diseases 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- 210000004556 brain Anatomy 0.000 description 3
- 230000001914 calming effect Effects 0.000 description 3
- 210000001168 carotid artery common Anatomy 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 230000009519 contusion Effects 0.000 description 3
- 230000034994 death Effects 0.000 description 3
- 230000002950 deficient Effects 0.000 description 3
- 230000035617 depilation Effects 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 230000029087 digestion Effects 0.000 description 3
- 239000002934 diuretic Substances 0.000 description 3
- 230000001882 diuretic effect Effects 0.000 description 3
- 208000001848 dysentery Diseases 0.000 description 3
- 230000002708 enhancing effect Effects 0.000 description 3
- 206010015037 epilepsy Diseases 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 238000000855 fermentation Methods 0.000 description 3
- 230000004151 fermentation Effects 0.000 description 3
- 238000005469 granulation Methods 0.000 description 3
- 230000003179 granulation Effects 0.000 description 3
- 208000006750 hematuria Diseases 0.000 description 3
- 241000411851 herbal medicine Species 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 201000001881 impotence Diseases 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 208000028867 ischemia Diseases 0.000 description 3
- 210000003127 knee Anatomy 0.000 description 3
- 210000002414 leg Anatomy 0.000 description 3
- 239000002398 materia medica Substances 0.000 description 3
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 3
- 229940100243 oleanolic acid Drugs 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 239000002574 poison Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- HZLWUYJLOIAQFC-UHFFFAOYSA-N prosapogenin PS-A Natural products C12CC(C)(C)CCC2(C(O)=O)CCC(C2(CCC3C4(C)C)C)(C)C1=CCC2C3(C)CCC4OC1OCC(O)C(O)C1O HZLWUYJLOIAQFC-UHFFFAOYSA-N 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 230000001047 pyretic effect Effects 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 206010040872 skin infection Diseases 0.000 description 3
- 230000000638 stimulation Effects 0.000 description 3
- 235000000346 sugar Nutrition 0.000 description 3
- 235000019640 taste Nutrition 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 231100000419 toxicity Toxicity 0.000 description 3
- 230000001988 toxicity Effects 0.000 description 3
- 230000008673 vomiting Effects 0.000 description 3
- PXGPLTODNUVGFL-BRIYLRKRSA-N (E,Z)-(1R,2R,3R,5S)-7-(3,5-Dihydroxy-2-((3S)-(3-hydroxy-1-octenyl))cyclopentyl)-5-heptenoic acid Chemical compound CCCCC[C@H](O)C=C[C@H]1[C@H](O)C[C@H](O)[C@@H]1CC=CCCCC(O)=O PXGPLTODNUVGFL-BRIYLRKRSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 206010000060 Abdominal distension Diseases 0.000 description 2
- 206010000077 Abdominal mass Diseases 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 201000001320 Atherosclerosis Diseases 0.000 description 2
- 206010063659 Aversion Diseases 0.000 description 2
- 206010008531 Chills Diseases 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 206010021118 Hypotonia Diseases 0.000 description 2
- 206010023126 Jaundice Diseases 0.000 description 2
- 206010027514 Metrorrhagia Diseases 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 102000008299 Nitric Oxide Synthase Human genes 0.000 description 2
- 108010021487 Nitric Oxide Synthase Proteins 0.000 description 2
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 2
- 208000025747 Rheumatic disease Diseases 0.000 description 2
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 2
- 208000032023 Signs and Symptoms Diseases 0.000 description 2
- 208000005392 Spasm Diseases 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 206010047531 Visual acuity reduced Diseases 0.000 description 2
- 229930003451 Vitamin B1 Natural products 0.000 description 2
- 208000005946 Xerostomia Diseases 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 206010003549 asthenia Diseases 0.000 description 2
- 208000034158 bleeding Diseases 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 208000013116 chronic cough Diseases 0.000 description 2
- 239000000571 coke Substances 0.000 description 2
- 239000003433 contraceptive agent Substances 0.000 description 2
- 208000029078 coronary artery disease Diseases 0.000 description 2
- 230000007850 degeneration Effects 0.000 description 2
- 230000002951 depilatory effect Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 230000006866 deterioration Effects 0.000 description 2
- 208000017574 dry cough Diseases 0.000 description 2
- 206010013781 dry mouth Diseases 0.000 description 2
- 230000010482 emotional regulation Effects 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 208000017561 flaccidity Diseases 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 210000000232 gallbladder Anatomy 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 208000035861 hematochezia Diseases 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 210000000629 knee joint Anatomy 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 210000005229 liver cell Anatomy 0.000 description 2
- 210000003141 lower extremity Anatomy 0.000 description 2
- 201000007227 lymph node tuberculosis Diseases 0.000 description 2
- 230000003211 malignant effect Effects 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 230000027758 ovulation cycle Effects 0.000 description 2
- 230000008506 pathogenesis Effects 0.000 description 2
- 230000010412 perfusion Effects 0.000 description 2
- NDTYTMIUWGWIMO-UHFFFAOYSA-N perillyl alcohol Chemical compound CC(=C)C1CCC(CO)=CC1 NDTYTMIUWGWIMO-UHFFFAOYSA-N 0.000 description 2
- RUMOYJJNUMEFDD-UHFFFAOYSA-N perillyl aldehyde Chemical compound CC(=C)C1CCC(C=O)=CC1 RUMOYJJNUMEFDD-UHFFFAOYSA-N 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 230000000171 quenching effect Effects 0.000 description 2
- 238000004064 recycling Methods 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- 230000002441 reversible effect Effects 0.000 description 2
- 230000000552 rheumatic effect Effects 0.000 description 2
- 230000000630 rising effect Effects 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 239000011669 selenium Substances 0.000 description 2
- 229910052711 selenium Inorganic materials 0.000 description 2
- 235000011649 selenium Nutrition 0.000 description 2
- 230000035943 smell Effects 0.000 description 2
- 235000014347 soups Nutrition 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- 230000004206 stomach function Effects 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- 229960003495 thiamine Drugs 0.000 description 2
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 230000002936 tranquilizing effect Effects 0.000 description 2
- 230000008736 traumatic injury Effects 0.000 description 2
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 210000003932 urinary bladder Anatomy 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- 235000010374 vitamin B1 Nutrition 0.000 description 2
- 239000011691 vitamin B1 Substances 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- WZUVPPKBWHMQCE-XJKSGUPXSA-N (+)-haematoxylin Chemical compound C12=CC(O)=C(O)C=C2C[C@]2(O)[C@H]1C1=CC=C(O)C(O)=C1OC2 WZUVPPKBWHMQCE-XJKSGUPXSA-N 0.000 description 1
- NFLGAXVYCFJBMK-RKDXNWHRSA-N (+)-isomenthone Natural products CC(C)[C@H]1CC[C@@H](C)CC1=O NFLGAXVYCFJBMK-RKDXNWHRSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- XUCIJNAGGSZNQT-JHSLDZJXSA-N (R)-amygdalin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O[C@@H](C#N)C=2C=CC=CC=2)O1 XUCIJNAGGSZNQT-JHSLDZJXSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 108010085238 Actins Proteins 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- ATWHGWYKSFRYBN-UHFFFAOYSA-N Amygdaloside Natural products O1C(=O)C2(C)CCCC(C3CC4)(C)C2C1OCC3(C1)CC4C1(O)COC1OC(CO)C(O)C(O)C1O ATWHGWYKSFRYBN-UHFFFAOYSA-N 0.000 description 1
- 206010002368 Anger Diseases 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 244000141006 Armeniaca sibirica Species 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 1
- 206010008631 Cholera Diseases 0.000 description 1
- 206010008909 Chronic Hepatitis Diseases 0.000 description 1
- 206010053567 Coagulopathies Diseases 0.000 description 1
- 241000756943 Codonopsis Species 0.000 description 1
- 208000002881 Colic Diseases 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 206010052804 Drug tolerance Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010048554 Endothelial dysfunction Diseases 0.000 description 1
- 208000008967 Enuresis Diseases 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 239000005770 Eugenol Substances 0.000 description 1
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 1
- 241000146384 Glaux Species 0.000 description 1
- 208000018779 Globus Sensation Diseases 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- WZUVPPKBWHMQCE-UHFFFAOYSA-N Haematoxylin Natural products C12=CC(O)=C(O)C=C2CC2(O)C1C1=CC=C(O)C(O)=C1OC2 WZUVPPKBWHMQCE-UHFFFAOYSA-N 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 206010019668 Hepatic fibrosis Diseases 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- 206010020565 Hyperaemia Diseases 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 102100034343 Integrase Human genes 0.000 description 1
- 206010061245 Internal injury Diseases 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 1
- 229930064664 L-arginine Natural products 0.000 description 1
- 235000014852 L-arginine Nutrition 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- NFLGAXVYCFJBMK-UHFFFAOYSA-N Menthone Chemical compound CC(C)C1CCC(C)CC1=O NFLGAXVYCFJBMK-UHFFFAOYSA-N 0.000 description 1
- 206010062575 Muscle contracture Diseases 0.000 description 1
- 206010050819 Musculoskeletal chest pain Diseases 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- 108090000913 Nitrate Reductases Proteins 0.000 description 1
- IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 235000019082 Osmanthus Nutrition 0.000 description 1
- 241000333181 Osmanthus Species 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 241000590428 Panacea Species 0.000 description 1
- 240000005373 Panax quinquefolius Species 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 241001080798 Polygala tenuifolia Species 0.000 description 1
- 241000756042 Polygonatum Species 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 206010036590 Premature baby Diseases 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 241000219780 Pueraria Species 0.000 description 1
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
- 241000700157 Rattus norvegicus Species 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 102000007562 Serum Albumin Human genes 0.000 description 1
- 108010071390 Serum Albumin Proteins 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 206010041497 Spermatorrhoea Diseases 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 229930183118 Tanshinone Natural products 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- 208000036029 Uterine contractions during pregnancy Diseases 0.000 description 1
- 206010046788 Uterine haemorrhage Diseases 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 210000004100 adrenal gland Anatomy 0.000 description 1
- 238000005054 agglomeration Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 230000000954 anitussive effect Effects 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000001088 anti-asthma Effects 0.000 description 1
- 230000003260 anti-sepsis Effects 0.000 description 1
- 230000002180 anti-stress Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000000924 antiasthmatic agent Substances 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 229940124584 antitussives Drugs 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 238000003149 assay kit Methods 0.000 description 1
- 230000000680 avirulence Effects 0.000 description 1
- 210000001142 back Anatomy 0.000 description 1
- 208000002894 beriberi Diseases 0.000 description 1
- 230000002146 bilateral effect Effects 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 238000012742 biochemical analysis Methods 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 238000004820 blood count Methods 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 230000003925 brain function Effects 0.000 description 1
- 230000009172 bursting Effects 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 235000001465 calcium Nutrition 0.000 description 1
- 230000005907 cancer growth Effects 0.000 description 1
- 108010089934 carbohydrase Proteins 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 230000001925 catabolic effect Effects 0.000 description 1
- 230000003727 cerebral blood flow Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 231100000132 chronic toxicity testing Toxicity 0.000 description 1
- 230000035602 clotting Effects 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 208000006111 contracture Diseases 0.000 description 1
- 208000012839 conversion disease Diseases 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 230000003001 depressive effect Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 239000003866 digestant Substances 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 102000038379 digestive enzymes Human genes 0.000 description 1
- 108091007734 digestive enzymes Proteins 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000002996 emotional effect Effects 0.000 description 1
- 210000004696 endometrium Anatomy 0.000 description 1
- 230000008694 endothelial dysfunction Effects 0.000 description 1
- 210000003725 endotheliocyte Anatomy 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000001952 enzyme assay Methods 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 229960002217 eugenol Drugs 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 201000005577 familial hyperlipidemia Diseases 0.000 description 1
- 239000010685 fatty oil Substances 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 210000001105 femoral artery Anatomy 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 206010016766 flatulence Diseases 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000005714 functional activity Effects 0.000 description 1
- 108010074605 gamma-Globulins Proteins 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 230000035784 germination Effects 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 230000026781 habituation Effects 0.000 description 1
- 230000035931 haemagglutination Effects 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 230000000004 hemodynamic effect Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 231100000753 hepatic injury Toxicity 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 210000003494 hepatocyte Anatomy 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 210000003701 histiocyte Anatomy 0.000 description 1
- 230000003118 histopathologic effect Effects 0.000 description 1
- 235000003642 hunger Nutrition 0.000 description 1
- 210000003026 hypopharynx Anatomy 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 238000002991 immunohistochemical analysis Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 230000000622 irritating effect Effects 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 210000000867 larynx Anatomy 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 208000013433 lightheadedness Diseases 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 231100001252 long-term toxicity Toxicity 0.000 description 1
- 208000024714 major depressive disease Diseases 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 239000011572 manganese Substances 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 201000003995 melancholia Diseases 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 229930007503 menthone Natural products 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 230000008965 mitochondrial swelling Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 239000002840 nitric oxide donor Substances 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 229960002969 oleic acid Drugs 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 238000001543 one-way ANOVA Methods 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 210000004681 ovum Anatomy 0.000 description 1
- 230000003119 painkilling effect Effects 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 206010034754 petechiae Diseases 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 235000014786 phosphorus Nutrition 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 235000007686 potassium Nutrition 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 206010036596 premature ejaculation Diseases 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 150000003180 prostaglandins Chemical class 0.000 description 1
- 230000009325 pulmonary function Effects 0.000 description 1
- 238000004080 punching Methods 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 238000010839 reverse transcription Methods 0.000 description 1
- 238000003757 reverse transcription PCR Methods 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 230000001932 seasonal effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- -1 small molecule compound Chemical class 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000021595 spermatogenesis Effects 0.000 description 1
- 230000005982 spleen dysfunction Effects 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 238000012109 statistical procedure Methods 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 230000008093 supporting effect Effects 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 235000015961 tonic Nutrition 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 229960000716 tonics Drugs 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 230000006499 vasodilator function Effects 0.000 description 1
- 230000001196 vasorelaxation Effects 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 230000009978 visual deterioration Effects 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 210000004916 vomit Anatomy 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 235000011844 whole wheat flour Nutrition 0.000 description 1
- 239000010056 xuefu Substances 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 235000016804 zinc Nutrition 0.000 description 1
- 210000000216 zygoma Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/233—Bupleurum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/535—Perilla (beefsteak plant)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
- A61K36/575—Magnolia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
- A61K36/638—Ligustrum, e.g. Chinese privet
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/69—Polygalaceae (Milkwort family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/734—Crataegus (hawthorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/89—Cyperaceae (Sedge family)
- A61K36/8905—Cyperus (flatsedge)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8969—Polygonatum (Solomon's seal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
- A61K36/8998—Hordeum (barley)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/15—Preparation or pretreatment of starting material involving mechanical treatment, e.g. chopping up, cutting or grinding
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a health oral liquid for the treatment of qi-stagnancy and blood stasis. The oral liquid comprises the following raw materials in parts by weight: 10-20 parts of radix bupleuri, 10-20 parts of rhizoma cyperi, 10-20 parts of angelica sinensis, 10-20 parts of poria cocos, 10-20 parts of peach kernels, 10-20 parts of rhizoma ligustici wallichii, 10-20 parts of magnolia officinalis, 10-20 parts of astragalus membranaceus, 10-20 parts of perilla frutescens, 10-20 parts of polygonatum kingianum, 10-20 parts of fructus rubi, 10-20 parts of mulberries, 10-20 parts of charred triplet, 10-20 parts of fructus ligustri lucidi, 10-20 parts of salvia miltiorrhiza, 10-20 parts of flosmume, 10-20 parts of curcuma, 10-20 parts of polygala amflra, 10-20 parts of radix paeoniae rubra, and 10-20 parts of achyranthes bidentata. According to the invention, in the process of treating, by adopting treatment from the liver, and on the basis of treatment based on syndrome differentiation, while a drug for invigorating blood circulation and eliminating stasis is applied, liver-regulating drugs for soothing the liver, warming the liver, nourishing the liver, removing heat from the liver, and the like are respectively added, so that the health oral liquid achieves a good clinical curative effect on affect-mind ill-being together with chest and rib-side distending and distress, and stabbing pain, and Qi-stagnation and blood stasis symptoms such as menstrual disorders, menstrual pain, lassitude in loin and legs, leukorrhea with reddish discharge, lower abdomen deficiency and cold, abdominal pain during menstruation, congealing cold and blood stasis, easily oil face, sterility, and the like.
Description
Technical field
The present invention relates to the medicinal preparation containing deriving from plant, animal or raw mineral materials, particularly a kind of health care oral liquid for the treatment of qi depression to blood stasis and preparation method thereof.
Background technology
Qi depression to blood stasis, refers to the stagnation of QI and the simultaneous pathological state of blood stasis.Its Deterioration mechanism is: general how first not smooth by the operation of gas, then cause the operation stasis of blood of blood stagnant, first have the stagnation of QI, blood stasis is caused by the stagnation of QI, also by stagnation of blood stasis such as blood circulating out of vessels, can affect the operation of gas, this just first has blood stasis, the stagnation of QI is caused by blood stasis, also can the stagnation of QI and blood stasis be formed simultaneously because of sprain and contusion equivalent damage.
Qi depression to blood stasis disease, is depression and stagnation of QI and hyperamization clots absorbing hinders the sign occurred, how not to be relaxed by feelings will, or exopathogen invasion and attack cause irritability of a specified duration strongly fragrant do not understand caused by.Main clinical manifestation: breast side of body feeling of distension and oppression, walk to alter pain, being irritable and getting angry easily, the lower mass in the abdomen of the side of body, twinge tenderness, the visible menstruation apolipsis of women, or dysmenorrhea, dark menses block, purplish tongue or see ecchymosis, hesitant pulse.
Pathogenic analysis: assertive evidence does not relax with feelings will, simultaneously with breast side of body feeling of distension and oppression, twinge, woman's menoxenia is diagnostic point.Liver controlling conveyance and dispersion and store blood, having bar reaches mechanism of qi, the function of emotion regulation, the unsuccessful or exopathogen invasion and attack the liver pulse then irritability stasis of feelings will, and catharsis is neglected one's duty, therefore is in a very depressed state or irritable, and breast side of body feeling of distension and oppression, walks to alter pain; Qi as the commander of blood, stagnation of QI due to depression of the liver, with the passing of time puzzled, must cause in blood stasis and stop, therefore gradually become the lower mass in the abdomen of the side of body, twinge tenderness; Liver storing blood, be the source of women's menses, the liver blood stasis of blood is stagnant, and blood stasis is stagnated, and amasss in the sea of blood, and hinder menses descending, menses freely then do not cause amenorrhea, dysmenorrhea.Purplish tongue or have ecchymosis, hesitant pulse, is in blood stasis the disease stopped.
The life of qi depression to blood stasis body constitution is taken good care of: research finds, human body is in qi depression to blood stasis state for a long time, tissue ischemia, and state that cell is in " hunger ", can accelerate aging.Therefore, for qi depression to blood stasis body constitution, promoting flow of QI and blood has effect anti-aging in advance.On the living conditions, happy emotion should be kept, contribute to improving QI-blood circulation.Avoid the unhealthy emotions such as rage, terrified, troubled thoughts on the impact of QI-blood circulation.Adhere to sports, quantity of motion varies with each individual.Each motion exercise should reach the degree of slightly perspiring.
In theory of Chinese medical science, " gas " is the life thing extremely micro-to essence be present in human body, be the important substance basis of vital movement, there is very strong vigor, the generation of blood, operation can be promoted, and the effect such as the generation of body fluid, defeated cloth and excretion, there is living matter and physiological function double attribute.The traditional Chinese medical science about the discussion of " the capable then blood of gas, the stagnation of QI is blood stasis then for qi being the governor of blood, blood being the material foundation of QI ", the substantial connection reflecting the interaction of QI and blood in physiological and pathological and mutually cause a disease.The essence of further further investigated gas and qi-blood relationship, can provide new approach for treatment syndrome of blood stasis, have great importance to the research of combination of Chinese and Western medicine syndrome of blood stasis.
The formation of syndrome of qi stagnation and blood stasis is a veryer long process, relevant with factors such as emotion, diet, age, environment, diseases.The traditional Chinese medical science think the activity of spiritual feelings will be with internal organs change the vital essence blood of raw and storage for material base, and liver controlling conveyance and dispersion is anger in will, and anger take blood stored in the liver as material base, liver stored blood, regulating blood flow amount and prevent the hemorrhage liver catharsis mechanism of qi that depends on to be achieved.
Women's feelings will is not relaxed, and simultaneously with breast side of body feeling of distension and oppression, twinge, menoxenia, dysmenorrhea are commonly encountered diseases, affects its physically and mentally healthy and study to a certain extent.Western medical treatment mainly adopts non-steroidal anti-inflammatory drugs and contraceptive treatment, belongs to anti symptom treatment more, though get effect fast, often recur, and side effect is larger after drug withdrawal.Chinese traditional treatment dysmenorrhea accounts for clinically and has great advantage, evident in efficacy and side effect is little.The traditional Chinese medical science about the discussion of " the capable then blood of gas, the stagnation of QI is blood stasis then for qi being the governor of blood, blood being the material foundation of QI ", the substantial connection reflecting the interaction of QI and blood in physiological and pathological and mutually cause a disease.The essence of further further investigated gas and qi-blood relationship, can provide new approach for treatment syndrome of blood stasis, have great importance to the research of combination of Chinese and Western medicine syndrome of blood stasis.But Chinese medicine health-care effect varies with each individual, and specific aim is barely satisfactory, especially abnormal smells from the patient is poor, and mouthfeel is very poor.Chinese medicine odor is poor, and a lot of people is reluctant long-term taking; Even if take, be medicine three points of poison, allow during people's long-term taking and also produce resisting psychology.How the efficacy exertion of Chinese medicine health-care not being injured human body again to maximum, and obviously improve mouthfeel, people can be accepted, is our problem in the urgent need to address.
Summary of the invention
Technical problem to be solved by this invention is, Chinese medicine health-care effect varies with each individual, and specific aim is barely satisfactory, and especially abnormal smells from the patient is poor, and mouthfeel is very poor.Chinese medicine odor is poor, and a lot of people is reluctant long-term taking; Even if take, be medicine three points of poison, allow during people's long-term taking and also produce resisting psychology.How the efficacy exertion of Chinese medicine health-care not being injured human body again to maximum, and obviously improve mouthfeel, people can be accepted, is our problem in the urgent need to address.
The formation of syndrome of qi stagnation and blood stasis is a veryer long process, relevant with factors such as emotion, diet, age, environment, diseases.The traditional Chinese medical science think the activity of spiritual feelings will be with internal organs change the vital essence blood of raw and storage for material base, and liver controlling conveyance and dispersion is anger in will, and anger take blood stored in the liver as material base, liver stored blood, regulating blood flow amount and prevent the hemorrhage liver catharsis mechanism of qi that depends on to be achieved.But Chinese medicine health-care effect varies with each individual, specific aim is barely satisfactory, the present invention adopts treat from liver when treating, based on determination for the treatment of based on pathogenesis obtained through differentiation of symptoms and signs, add soothing the liver, warming the liver, nourishing the liver, liver heat removing etc. respectively at application drug for invigorating blood circulation and eliminating stasis simultaneously and adjust liver medicine, do not relax for feelings will, simultaneously with breast side of body feeling of distension and oppression, twinge; Menoxenia, abdominal pain in menstruation, lassitude loin and legs, leucorrhea with red and white discharge, lower abdomen cold caused by deficiency, menalgia, congealing cold with blood stasis, appearance be old, the symptom that do not become the qi depression to blood stasis such as pregnant for a long time easily, clinically obtains good curative effect.
For solving the problems of the technologies described above, the invention provides a kind of health care oral liquid for the treatment of qi depression to blood stasis, the parts by weight of the raw material of oral liquid described in it can be: Radix Bupleuri 10 ~ 20 parts, Rhizoma Cyperi 10 ~ 20 parts, Radix Angelicae Sinensis 10 ~ 20 parts, 10 ~ 20 parts, Poria, 10 ~ 20 parts, Semen Persicae, Rhizoma Chuanxiong 10 ~ 20 parts, Cortex Magnoliae Officinalis 10 ~ 20 parts, the Radix Astragali 10 ~ 20 parts, Folium Perillae 10 ~ 20 parts, Rhizoma Polygonati 10 ~ 20 parts, Fructus Rubi 10 ~ 20 parts, Fructus Mori 10 ~ 20 parts, JIAOSANXIAN (Fructus Crataegi, Fructus Hordei Germinatus, Massa Medicata Fermentata) 10 ~ 20 parts, Fructus Ligustri Lucidi 10 ~ 20 parts, Radix Salviae Miltiorrhizae 10 ~ 20 parts, FLOS MUME 10 ~ 20 parts, Radix Curcumae 10 ~ 20 parts, Radix Polygalae 10 ~ 20 parts, Radix Paeoniae Rubra 10 ~ 20 parts, Radix Achyranthis Bidentatae 10 ~ 20 parts.
The health care oral liquid of described treatment qi depression to blood stasis, the parts by weight of the raw material of oral liquid described in it can also be: Radix Bupleuri 10 ~ 15 parts, Rhizoma Cyperi 10 ~ 15 parts, Radix Angelicae Sinensis 10 ~ 15 parts, 10 ~ 15 parts, Poria, 10 ~ 15 parts, Semen Persicae, Rhizoma Chuanxiong 10 ~ 15 parts, Cortex Magnoliae Officinalis 10 ~ 15 parts, the Radix Astragali 10 ~ 15 parts, Folium Perillae 10 ~ 15 parts, Rhizoma Polygonati 10 ~ 15 parts, Fructus Rubi 10 ~ 20 parts, Fructus Mori 10 ~ 20 parts, JIAOSANXIAN (Fructus Crataegi, Fructus Hordei Germinatus, Massa Medicata Fermentata) 10 ~ 20 parts, Fructus Ligustri Lucidi 10 ~ 20 parts, Radix Salviae Miltiorrhizae 10 ~ 20 parts, FLOS MUME 10 ~ 20 parts, Radix Curcumae 10 ~ 20 parts, Radix Polygalae 10 ~ 20 parts, Radix Paeoniae Rubra 10 ~ 20 parts, Radix Achyranthis Bidentatae 10 ~ 20 parts.
The health care oral liquid of described treatment qi depression to blood stasis, the parts by weight of the raw material of oral liquid described in it also can be: Radix Bupleuri 10 ~ 20 parts, Rhizoma Cyperi 10 ~ 20 parts, Radix Angelicae Sinensis 10 ~ 20 parts, 10 ~ 20 parts, Poria, 10 ~ 20 parts, Semen Persicae, Rhizoma Chuanxiong 10 ~ 20 parts, Cortex Magnoliae Officinalis 10 ~ 20 parts, the Radix Astragali 10 ~ 20 parts, Folium Perillae 10 ~ 20 parts, Rhizoma Polygonati 10 ~ 20 parts, Fructus Rubi 10 ~ 15 parts, Fructus Mori 10 ~ 15 parts, JIAOSANXIAN (Fructus Crataegi, Fructus Hordei Germinatus, Massa Medicata Fermentata) 10 ~ 15 parts, Fructus Ligustri Lucidi 10 ~ 15 parts, Radix Salviae Miltiorrhizae 10 ~ 15 parts, FLOS MUME 10 ~ 15 parts, Radix Curcumae 10 ~ 15 parts, Radix Polygalae 10 ~ 15 parts, Radix Paeoniae Rubra 10 ~ 15 parts, Radix Achyranthis Bidentatae 10 ~ 15 parts.
For solving the problems of the technologies described above, the present invention also provides a kind of preparation method for the treatment of the health care oral liquid of qi depression to blood stasis, and described in it, the preparation process of oral liquid comprises:
A, all raw material components to be soaked in ethanol 24 hours;
B, again by crude drug heat extract 2 times, become paste, be component 1;
C, medicinal residues add water and extract, as component 2;
D, above-mentioned two kinds of components to be merged, be condensed into pasty state add Mel or dextrin be in harmonious proportion after canned.
In described step a, all raw material powders can be broken into granule, dry, decontamination of winnowing with a dustpan, then be soaked in ethanol 24 hours.
In described step b, can by soaked heating raw materials reflux, extract, 2 times, each 1 ~ 2 hour, 2 extracting solution are merged and leaves standstill, remove supernatant, merge extractive liquid, leave standstill 24 hours, remove supernatant, when to put into thickener concentrating under reduced pressure relative density be 80 DEG C 1.36 extractum, stand for standby use, becomes component 1.
In described step c, all the other raw materials can be added 10 times of water gagings, then put into extraction pot heated and boiled 1 hour, filter, filtrate is for subsequent use; Filtering residue adds water, and second time heating, boils 45 minutes, and filter, filtrate is for subsequent use; Filtering residue adds water again, heated and boiled half an hour third time, filters; Three filtrates be combined, by filtered through gauze, add 50-60% ethanol in residue, 60 DEG C-70 DEG C are continued lixiviate 2h, and every 10min stirs once, filtered through gauze, merge lixiviating solution, are condensed into pasty state, become component 2.
In described steps d, can by component 1 and component also 2-in-1, then put into concentrating under reduced pressure tank, reclaim ethanol, when being concentrated into 90 DEG C, relative density is the extractum of 1.05, is concentrated into every 1ml containing 1g crude drug amount, then adds Mel or dextrin and is in harmonious proportion bottling.
For solving the problems of the technologies described above, the present invention reoffers a kind of preparation method for the treatment of the health care oral liquid of qi depression to blood stasis, and the preparation method of described oral liquid can also be following steps:
All raw materials are put into 10 times amount ethanol to soak more than 24 hours, heating and refluxing extraction 2 times, each 1 ~ 2 hour, 2 extracting solution are merged and leaves standstill, remove supernatant, merge extractive liquid, be the ultrafiltration post ultrafiltration of 5000-10000 again through the molecular weight that dams, when ultrafiltrate concentrating under reduced pressure relative density is 80 DEG C 1.36 extractum, heating be concentrated into paste, stand for standby use, becomes component 1; The medicinal residues that above-mentioned ethanol extraction is crossed are added 10 times of water gaging heating and refluxing extraction 2 times, each 1 ~ 2 hour, 2 extracting solution are merged and leaves standstill, remove supernatant, merge extractive liquid, then be the ultrafiltration post ultrafiltration of 5000-10000 through the molecular weight that dams, when ultrafiltrate concentrating under reduced pressure relative density is 80 DEG C 1.36 extractum, heating is concentrated into paste, stand for standby use, becomes component 2; Merged by above-mentioned two kinds of extracting solution, reducing pressure after reclaiming ethanol, it is concentrated to put into concentrator, then adds dextrin and is in harmonious proportion, pack after ultraviolet radiation for sterilizing and disinfecting.
In above-mentioned steps, two kinds of extracting solution can be merged, after reclaiming ethanol decompression put into concentrator concentrated time, when being concentrated into 90 DEG C, relative density is the concentrated solution of 1.05, sets to 0 ~ 5 DEG C of deepfreezes 24 hours; Cold preservation liquid is added the filter aid kieselguhr of 0.3%, filter, filtrate is inserted in economic benefits and social benefits vacuum concentrator again, is concentrated into every 1ml containing 1g crude drug amount.
Advantageous Effects of the present invention is: the present invention can avoid using the side effect that brings of Western medicine, and the formation of Western medicine syndrome of qi stagnation and blood stasis is a veryer long process, relevant with the factors such as emotion, diet, age, environment, disease.The traditional Chinese medical science think the activity of spiritual feelings will be with internal organs change the vital essence blood of raw and storage for material base, and liver controlling conveyance and dispersion is anger in will, and anger take blood stored in the liver as material base, liver stored blood, regulating blood flow amount and prevent the hemorrhage liver catharsis mechanism of qi that depends on to be achieved.But Chinese medicine health-care effect varies with each individual, specific aim is barely satisfactory, the present invention adopts treat from liver when treating, based on determination for the treatment of based on pathogenesis obtained through differentiation of symptoms and signs, add soothing the liver, warming the liver, nourishing the liver, liver heat removing etc. respectively at application drug for invigorating blood circulation and eliminating stasis simultaneously and adjust liver medicine, do not relax for feelings will, simultaneously with breast side of body feeling of distension and oppression, twinge; Menoxenia, abdominal pain in menstruation, lassitude loin and legs, leucorrhea with red and white discharge, lower abdomen cold caused by deficiency, menalgia, congealing cold with blood stasis, appearance be old, the symptom that do not become the qi depression to blood stasis such as pregnant for a long time easily, clinically obtains good curative effect.The present invention is pure drug matching, without any toxic and side effects, can life-time service, and instant effect, not easily recur after healing.
Detailed description of the invention
The formation of syndrome of qi stagnation and blood stasis is a veryer long process, relevant with factors such as emotion, diet, age, environment, diseases.The traditional Chinese medical science think the activity of spiritual feelings will be with internal organs change the vital essence blood of raw and storage for material base, and liver controlling conveyance and dispersion is anger in will, and anger take blood stored in the liver as material base, liver stored blood, regulating blood flow amount and prevent the hemorrhage liver catharsis mechanism of qi that depends on to be achieved.In this test, rat causes feelings will to change through multifactor combined stimulation, is in rage state for a long time, thus forms this card.
Qi depression to blood stasis, refers to the stagnation of QI and the simultaneous pathological state of blood stasis.Its Deterioration mechanism is: general how first not smooth by the operation of gas, then cause the operation stasis of blood of blood stagnant, first have the stagnation of QI, blood stasis is caused by the stagnation of QI, also by stagnation of blood stasis such as blood circulating out of vessels, can affect the operation of gas, this just first has blood stasis, the stagnation of QI is caused by blood stasis, also can the stagnation of QI and blood stasis be formed simultaneously because of sprain and contusion equivalent damage.
Qi depression to blood stasis disease, is depression and stagnation of QI and hyperamization clots absorbing hinders the sign occurred, how not to be relaxed by feelings will, or exopathogen invasion and attack cause irritability of a specified duration strongly fragrant do not understand caused by.Main clinical manifestation: breast side of body feeling of distension and oppression, walk to alter pain, being irritable and getting angry easily, the lower mass in the abdomen of the side of body, twinge tenderness, the visible menstruation apolipsis of women, or dysmenorrhea, dark menses block, purplish tongue or see ecchymosis, hesitant pulse.
Pathogenic analysis: assertive evidence does not relax with feelings will, simultaneously with breast side of body feeling of distension and oppression, twinge, woman's menoxenia is diagnostic point.Liver controlling conveyance and dispersion and store blood, having bar reaches mechanism of qi, the function of emotion regulation, the unsuccessful or exopathogen invasion and attack the liver pulse then irritability stasis of feelings will, and catharsis is neglected one's duty, therefore is in a very depressed state or irritable, and breast side of body feeling of distension and oppression, walks to alter pain; Qi as the commander of blood, stagnation of QI due to depression of the liver, with the passing of time puzzled, must cause in blood stasis and stop, therefore gradually become the lower mass in the abdomen of the side of body, twinge tenderness; Liver storing blood, be the source of women's menses, the liver blood stasis of blood is stagnant, and blood stasis is stagnated, and amasss in the sea of blood, and hinder menses descending, menses freely then do not cause amenorrhea, dysmenorrhea.Purplish tongue or have ecchymosis, hesitant pulse, is in blood stasis the disease stopped.
In theory of Chinese medical science, " gas " is the life thing extremely micro-to essence be present in human body, be the important substance basis of vital movement, there is very strong vigor, the generation of blood, operation can be promoted, and the effect such as the generation of body fluid, defeated cloth and excretion, there is living matter and physiological function double attribute.The traditional Chinese medical science about the discussion of " the capable then blood of gas, the stagnation of QI is blood stasis then for qi being the governor of blood, blood being the material foundation of QI ", the substantial connection reflecting the interaction of QI and blood in physiological and pathological and mutually cause a disease.The essence of further further investigated gas and qi-blood relationship, can provide new approach for treatment syndrome of blood stasis, have great importance to the research of combination of Chinese and Western medicine syndrome of blood stasis.
Semen Persicae bitter, sweet, flat.GUIXIN, liver, large intestine channel.Function cures mainly: blood circulation promoting and blood stasis dispelling, loosening bowel to relieve constipation, relieving cough and asthma.For amenorrhea, dysmenorrhea , WEIJIA mass in the abdomen, injury from falling down, dryness of the intestine constipation.Semen Persicae extracting solution obviously can increase cerebral blood flow, increases the blood flow of dog femoral artery, reduces vascular resistance, improves hemodynamic situation.Extract can improve the liver surface microcirculation of animal, and promotes bile secretion.Semen Persicae can make the hemorrhage of mice and clotting time obviously extend, and decoct has inhibitory action to external thrombus, and decocting liquid has fiber facilitation.Containing the fatty oil Castor Oil intestinal of 45% in Semen Persicae, be beneficial to defecation.Semen Persicae can promote primipara's uterine contraction and hemorrhage.Water decoction and extract have analgesia, antiinflammatory, antibacterial, anti-allergic effects.Amygdaloside in Semen Persicae has the effect of antitussive and antiasthmatic and anti-hepatic fibrosis." medication heart method ": Semen Persicae, bitter to let out stagnant blood, sweet with tissue regeneration promoting blood, therefore blood coagulation must be used.Heat in dehematizing again." detailed outline ": Semen Persicae promoting the circulation of blood, should use in the life of gross weight point; Moisturizing and invigorate blood circulation, soup leaching should remove the peel sharp parching to brown use, or Testa Tritici is with frying, or charred medicinal herb with its property retained, respectively with we.
Rhizoma Chuanxiong is pungent, temperature.Return liver, gallbladder, pericardium channel.Function blood-activating and qi-promoting, wind-expelling pain-stopping.For menoxenia, amenorrhea dysmenorrhea, lump in the abdomen is suffered from abdominal pain, the twinge of the breast side of body, tumbling and swelling, headache, rheumatic arthralgia.Rhizoma Chuanxiong is warm in nature, is gynecological's common drug, has the effect of activating blood cirulation to regulate QI flow.
The Radix Astragali has the effects such as invigorating QI to consolidate the body surface resistance, diuretic detumescent, expelling pus and toxin by strengthening QI, granulation promoting.Modern study, the Radix Astragali is containing the various trace elements such as Saponin, sucrose, polysaccharide, several amino acids, folic acid and selenium, zinc, copper.Have enhancing human body immunity function, protect the liver, diuresis, defying age, anti-stress, blood pressure lowering and antibacterial action more widely.But table excess pathogen is contained, retention of dampness due to stagnation of QI, and food stagnation is stagnated, carbuncle from the beginning of or the excess syndrome such as pyretic toxicity Shang Sheng after bursting.The Radix Astragali has invigorating QI to consolidate the body surface resistance, diuresis poison holding, evacuation of pus, effect of expelling pus and promoting granulation.Weak for the deficiency of vital energy, anorexia and loose stool, sinking of QI of middle-JIAO, chronic diarrhea proctoptosis, metrorrhagia of having blood in stool, exterior deficiency spontaneous perspiration, carbuncle difficulty is burst, and burst for a long time and do not hold back, blood deficiency and yellow complexion, interior-heat is quenched one's thirst." herbal classic " is recorded: " main carbuncle, loses skin ulcer for a long time, evacuation of pus pain relieving.Tonify deficiency, children's's all kinds of diseases and ailments." " Japan hanako materia medica " record: " help gas strengthening bone and muscle, put on flesh and enrich blood.”
The pungent micro-hardship of Rhizoma Cyperi is sweet, and flat function cures mainly: resolving depression of regulating the flow of vital energy, menstruction regulating and pain relieving.For stagnation of QI due to depression of the liver, breast, the side of body, abdominal distention, dyspepsia, menoxenia, amenorrhea dysmenorrhea, colic of cold type is suffered from abdominal pain, distending pain of the breast." detailed outline " carries it: loose seasonal epidemic pathogens is trembled with fear epidemic disease, and profit three is burnt, and separate six kinds of stagnation-syndromes, the diet that disappears gathers, phlegm retention feeling of fullness, edema of dorsum of the foot, abdominal distention, beriberi, only trusted subordinate, limbs, head, order, tooth, all pains of ear, ulcer sores, spits blood, hematochezia, hematuria, married woman's bleeding not during menses, the moon wait uncomfortable, before tire puerperal all kinds of diseases and ailments.
Radix Angelicae Sinensis, its sweet in the mouth and weighing, therefore specially can enrich blood, its gas is light and pungent, therefore again can promoting the circulation of blood, and invigorating middle warmer has, has benefit, the gas medicine in sincere blood, the panacea also in blood in row.Then mending to mend of about assistant, therefore can nutrition blood be supported, QI invigorating spermatogenesis, settling five organs, strong body, beneficial mind, all tangible deficient diseases, unsuitable without institute.Assistant to attack, lead to, therefore pain relieving constipation of dispelling, relieving rigidity of muscles and joints, controls contracture, paralysis, the card such as dry, puckery.Nutrient QI being deficient and exterior syndrome being not relieved person, help with agent such as bavin, Pueraria lobota, fiber crops, osmanthus, and can fall apart greatly Biao Weire, and show not hold back person, helps with Radix Et Rhizoma Rhei and so on, again can consolidating superficial resistance.Precisely because gas Xin Erdong, therefore for its quiet person when keeping away it, the sliding benefaction of property, stool does not consolidate person when keeping away it.All cloudy moderate heat Sheng persons, the active blood of Radix Angelicae Sinensis, also non-institute is suitable, and cloudy deficiency of YANG of middle-JIAO person, Radix Angelicae Sinensis can nourish blood, and is indispensable.
Radix Bupleuri clearind deficient heat Chinese medicine, comes off for cold, fever, alternate attack of chill and fever, malaria, stagnation of QI due to depression of the liver, sternal rib pain, proctoptosis, uterus, menoxenia.Radix Bupleuri begins to be loaded in Shennong's Herbal, is classified as top grade.The phytomorph of history tree to Radix Bupleuri has description more." book on Chinese herbal medicine is just ": " Radix Bupleuri, cool loose with it with this person, the heat of suppressing the hyperactive liver.It is cool in nature, therefore separates alternate attack of chill and fever, flesh table hectic fever, and liver and gall fire is scorching, and chest and hypochondrium is tied, and doublely controls skin infection, and blood room is heated; Its property is fallen apart, therefore main typhoid fever pathogenic heat are not separated, epidemic febrile disease intenseness of heat, SHAO YANG headache, Liver Channel melancholia.
Folium Perillae: tender leaf is nutritious, containing compositions such as protein, fat, soluble sugar, dietary fiber, carotene, vitamin B1, vitamin B2, vitamin C, potassium, calcium, phosphorus, ferrum, manganese and selenium, in addition, containing volatile oil in leaf, include perillaldehyde, perilla alcohol, menthone, menthol, eugenol and ergomaketon etc., have special fragrance, have antisepsis.Folium Perillae acrid in the mouth warm in nature, have induce sweat, cold expelling, the effect of regulating the flow of vital energy and seeking.Be applicable to the diseases such as cold, fever with aversion to cold, cough, asthma, distension and fullness of the chest and abdomen.Folium Perillae, based on edible tender leaf, can be eaten raw or cook soup.Folium Perillae is edible leaf not only, and its seed also because of the edible containing compositions such as high protein, oryzanol, vitamin E, vitamin B1, linolenic acid, linoleic acid, oleic acid, sterol, phospholipid, and has therapeutical effect to cough with dyspnea, phlegm dyspnea, the stagnation of QI, constipation etc.Find after deliberation, the each position of Folium Perillae evenly has good antitumaous effect, especially stronger with the effect in blade, oleanolic acid is wherein a kind of very strong natural anti-cancer agent, there is the effect of prophylaxis of tumours, there is again the effect of antiinflammatory, calmness, heart tonifying, diuresis, enhancing immunity, blood fat reducing and resistance growth of cancer cells.Folium Perillae property and flavor of peppery and warm, have deliver, cold expelling, the effect of regulating the flow of vital energy and seeking.Cure cold wind and cold, fever with aversion to cold, cough, asthma, distension and fullness of the chest and abdomen etc.Compendium of Material Medica is carried " promoting the circulation of QI to alleviate the stagnation in middle-JIAO, clearing away phlegm profit lung, and blood, warming middle-JIAO, pain relieving, Dingchuan, antiabortive ".
Rhizoma Polygonati: Rhizoma Polygonati is used as medicine with rhizome.There is boosting qi and nourishing yin, spleen invigorating, lung moistening, kidney benefiting functions.For alleviating weakness of the spleen and stomach, fatigue and asthenia, xerostomia lack of appetite, deficiency of the lung cough caused by dryness, asthenia of essence and blood, interior-heat such as to be quenched one's thirst the disease.Very effective in cure for diabetes.Rhizoma Polygonati has blood pressure lowering, blood sugar lowering, blood fat reducing, atherosclerosis, and slow down aging and the effect such as antibacterial, polygonatum polysaccharide has Immunestimulatory effect.For lung-dryness syndrome due to deficiency of YIN, the few expectorant of dry cough, and the chronic cough chronic cough etc. of YIN-deficiency of the lung and kidney.For weakness of the spleen and stomach.Both tonifying spleen-yin, again strengthening the spleen gas, obtain dizzy, soreness of the waist and knees for deficiency of kidney essence, early whitening of beard and hair and quenching one's thirst.Rhizoma Polygonati strengthening bone and muscle, beneficial marrow, bleaches and sends out; The cough expectorant be suitable for caused by lack of lung-YIN is few, dry cough without phlegm, the diseases such as hemoptysis.
Fructus Rubi is warm in nature; Sweet, sour; Return kidney, urinary bladder channel.Cure mainly: kidney tonifying, controlling nocturnal emission with astringent drugs, reducing urination.For enuresis due to deficiency of the kidney, frequent micturition, impotence and premature ejaculation, emission and spermatorrhea." Bencao Jingshu ": " Fructus Rubi, its main QI invigorating person, says beneficial vital essence also.Kidney storing essence, kidney improving inspiration by invigorating kidney-QI, vital essence is sufficient, then body is from light, sends out in vain also.Respectful main tonify deficiency of reviving is absolutely continuous, reinforcing YIN-essence Jianyang, smoothing skin, peace and internal organs.The main man's kidney-jing deficiency of Zhen Quan exhausts, impotence, woman's food have son.Large bright main settling five organs, beneficial color, supports vital essence, long hair, Qiang Zhi.All get its kidney tonifying and add essence, the adopted ear of sweet acid convergence." " property of medicine opinion " carry its: " main man's kidney-jing deficiency exhausts, woman's food have son.Main impotence.
Fructus Mori nourishing YIN and benefiting blood medicine; Promote the production of body fluid medicine; Aperitive.To enrich blood YIN nourishing, promote the production of body fluid and moisturize.For vertigo and tinnitus, palpitation and insomnia, early whitening of beard and hair, Tianjin wound is thirsty, and interior-heat is quenched one's thirst, blood deficiency and constipation.Tonifying liver, kidney tonifying, relieves dizziness, high fever, infantile convulsions, epilepsy, etc., and grows liquid.Control hepatic and renal YIN deficiency, quench one's thirst, constipation, order is dark, tinnitus, scrofula, articular instability.Both can food, can be used as medicine again, the traditional Chinese medical science thinks the acid of Fructus Mori sweet in the mouth, and cold nature, enters the heart, liver, kidney channel, is strengthening by means of tonics, the good fruit of the heart nourishing and intellengence improving.There is YIN nourishing of enriching blood, promoting the production of body fluid to quench thirst, the effects such as intestine moistening is dry, cure mainly deficiency of YIN-blood and having a dizzy spell of causing, tinnitus cardiopalmus, irritated insomnia, soreness of the waist and knees, early whitening of beard and hair, xerostomia of quenching one's thirst, the diseases such as constipation with dry stool.
Fructus Ligustri Lucidi is used for the poor vision of the hepatic and renal YIN deficiency, visual deterioration, early whitening of beard and hair, soreness of waist tinnitus and fever due to yin deficiency etc.This product energy tonifying liver kidney yin, but the efficacy of a drug is gentle, slowly must get effect.Control poor vision, often join Radix Asparagi, Fructus Lycii is equal to use, controls early whitening of beard and hair, and often join the same use of Fructus Mori, fever due to yin deficiency, often joins Cortex Lycii.The hepatic and renal YIN deficiency, Light-headedness, seminal emission tinnitus, soreness of the waist and knees, early whitening of beard and hair, coronary heart disease, hyperlipemia, hypertension, chronic hepatitis.The protective effect research of liver is thought, Fructus Ligustri Lucidi contains oleanolic acid, to rat skin lower injection, serum glutamic pyruvic transminase can be reduced, there is obvious protective effect to the hepatic injury of Carbon Tetrachloride Induced, and can liver cell regeneration be promoted. oleanolic acid also can make triglyceride accumulation minimizing in liver, hepatocellular degeneration necrosis obviously alleviates, glycogen accumulation increases, serum γglobulin declines; Ultrastructure visible hepatocyte mitochondrial swelling and endosomal vesicle degeneration alleviate, hepatic tissue interstitial inflammation habituation.
Radix Salviae Miltiorrhizae is bitter, is slightly cold.GUIXIN, Liver Channel.Stasis-dispelling and pain-killing, promoting blood circulation to restore menstrual flow, clear away heart-fire relieving restlessness.For menoxenia, amenorrhea dysmenorrhea, lump in the abdomen, breast ventral spine pain, pyretic arthralgia pain, skin infection swells and ache, dysphoria and insomnia.For costa sternales hypochondriac pain, rheumatic arthralgia, lump in the abdomen lumps, and skin infection swells and ache, and tumbling down is grieved, menoxenia, amenorrhea dysmenorrhea, puerperal stasis of blood pain etc.Treatment costa sternales pain, lump in the abdomen caking, and menoxenia, amenorrhea dysmenorrhoea have good effect.. " detailed outline " carries: Radix Salviae Miltiorrhizae, and by " the sensible opinion of married woman " cloud, SIWU TANG controls gynecopathy, pays no attention to antenatal puerperal, how many through water, all can be general, and only taste Radix Salviae Miltiorrhizae falls apart, and cures mainly identical with it.Lid Radix Salviae Miltiorrhizae can break stagnated blood, and mend fresh blood, peaceful tire, fall stillborn fetus, only metrorrhagia dysentery, regulating menstruation arteries and veins.Main Compositions of Radix Salviae Miltiorrhizae TANSHINONES has blood vessel dilating, improves circulation, removes the effects such as intravascular coagulation, has effect of invigorating blood circulation trace, and can promote that liver blood circulates, be beneficial to liver cell regeneration.
The micro-acid of FLOS MUME, puckery, nontoxic.Soothing liver-QI, stomach function regulating, reduces phlegm.Control globus hystericus, stomachache due to hyperactive liver-QI attacking the stomach, inappetence, dizzy, scrofula.FLOS MUME pattern is pure white, and fragrance is extremely dense, has the laudatory title of " spending middle gentleman ".Its property is put down, and maximum feature can be regulated the flow of vital energy exactly, and function of spleen and stomach regulating unclogs and readjusts QI and blood, but can not impairment of YIN, very seldom.So be no matter the old man of family, or immature baby, can keep healthy by FLOS MUME.Be usually used in gloomy vexed, the disease such as stomachache due to hyperactive liver-QI attacking the stomach, inappetence.The external of FLOS MUME water can also prevent facial blood stasis to form speckle.Supplementary Amplifications of the Compendium of Materia Medica: " " all sorts of flowers mirror ": powder for improving appetite is evil, and food of cooking congee, help the gas of sun clearly to rise, distillation point tea, promoting the production of body fluid to quench thirst, expelling summer-heat is washed tired." " decoction pieces is newly joined ": " FLOS MUME suppressing the hyperactive liver and easing the stomach, only gastralgia, dizziness, enter diet.”
Radix Curcumae is pungent, bitter, cold.Return liver, the heart, lung meridian.Function cures mainly: promoting blood circulation and stopping pain, promoting QI circulation for relieving depression, and clear away heart-fire removing heat from blood, promoting the function of the gallbladder to alleviate jaundice.For amenorrhea dysmenorrhea, chest and abdomen swelling and pain, twinge, calentura coma, epilepsy is gone mad, jaundice dark coloured urine." property of medicine opinion ": control woman's stagnated blood epigastric pain caused by emotional factors, cold air knot is poly-, and warm vinegar rubs and takes it.Tang Materia Medica: main accumulation of blood, the therapeutic method to keep the adverse QI flowing downwards, granulation promoting, hemostasis, broken stagnant blood, stranguria with blood, hematuria, incised wound." book on Chinese herbal medicine just ": emesis blood, epistaxis; Alonely control married woman's cold air accumulation of blood, knot gather qi together is stagnant, and trusted subordinate has a pain." book on Chinese herbal medicine is stated ": control heating, strongly fragrant, cough, bleeding from the gum, cough blood, hematuria, has a headache dizzy, mad epilepsy, dysentery, drenches, and the cards such as eyes nose glossopharyngeum larynx.
Radix Polygalae (Radix Polygalae) is conventional Chinese medicine, be recorded in Shennong's Herbal the earliest, be classified as top grade, and be regarded as supporting life key medicine, derive from the dry root of milk wort Radix Polygalae Polygala tenuifolia Willd. and ovum leaf Radix Polygalae P.sibirica L..Warm in nature, bitter in the mouth, pungent, the function of have Fructus Alpiniae Oxyphyllae of calming the nerves, eliminate the phlegm, subsiding a swelling, the insomnia and dreamful sleep caused for disarmony between the heart and kidney, forgetful palpitation with fear, staring spells, expectoration is not well, sore swollen toxin, breast swell and pain.Shennong's Herbal: main cough with dyspnea damaging the spleen and stomach, tonifying for the deficiency, except pathogen, sharp nine orifices, Fructus Alpiniae Oxyphyllae is intelligent, normal hearing and eyesight, does not forget, strong will times power.
Radix Paeoniae Rubra: bitter in the mouth, cold nature.Return Liver Channel.There is the function of clearing away heat and cooling blood, eliminating stasis to stop pain.Raw Radix Paeoniae Rubra wins with clearing away heat and cooling blood power.The fever of the body being used for the epidemic febrile disease pathogenic heat attacking blood system in febrile diseases is hemorrhage, conjunctival congestion and swelling pain, carbuncle sore tumefacting virus.Wine Radix Paeoniae Rubra: with promoting blood circulation to remove blood stasis power victory, clearing away heat and cooling blood effect is more weak.Be used for amenorrhea or dysmenorrhea, traumatic injury.Radix Paeoniae Rubra can purify the blood a point excess-heat, and dissipating blood stasis blood is detained.This product function is close with Cortex Moutan, therefore normal and Cortex Moutan mutual reinforcement between is for use.But the effect of Cortex Moutan clearing away heat and cooling blood is better, can purify the blood a point excess-heat, can control fever due to yin deficiency again; And Radix Paeoniae Rubra can only be used for blood system excess-heat, be good at promoting blood circulation to remove blood stasis.
Radix Achyranthis Bidentatae invigorating the liver and kidney; Bone and muscle strengthening; Promoting blood circulation to restore menstrual flow; Ignite (blood) descending; Inducing diuresis for treating stranguria syndrome soreness of waist and knee joint; Flaccidity and weakness of the lower limbs; Amenorrhea due to stagnation of blood; Dysmenorrhea; Puerperal abdominal pain due to blood stasis; Lump in the abdomen; Retention of placenta; Pyretic stranguria; Stranguria with blood; Traumatic injury; Carbuncle malignant boil; Laryngopharynx swelling and pain.Radix Achyranthis Bidentatae, walks and can mend, and property is apt to descending, therefore enters Liver and kidney.Main cold-damp flaccidity syndrome and arthralgia syndrome, spasm of the limbs, gonalgia unable to flex and stretch the extremities person, liver spleen is suffered from a deficiency of the kidney, then cold-damp heresy visitor form numbness, and sick spasm of the limbs, gonalgia unable to flex and stretch the extremities.This property of medicine is walked and descending, and it can also must by eliminating impediment by cold-damp.Top capping liver then muscle is relaxed, descending, manages knee joint, and promoting the circulation of blood then pain stops.By vim and vigour, still cloud can lead to qi stagnation hemagglutination also." not Lu ": middle weak breath of curing the wound, male kidney yin disappears, and old man loses excessive, and invigorating middle warmer is absolutely continuous, fills out bone marrow, and except pain and pain along the spinal column in brain, married woman's moon water is obstructed, blood agglomeration, and benefit essence, Li Yin gas, only turns white.The effect of have diuresis, by force essence, stimulating the menstrual flow.Energy relaxing muscles and tendons to promote blood circulation, specially controls lumbocrural pain.
Poria sweet in the mouth, light, property are put down, and are used as medicine and have the function of promoting diuresis to eliminate damp pathogen, strengthening the spleen stomach function regulating, mind tranquilizing and the heart calming.Modern medicine study: Poria energy enhancing human body immunity function, pachyman has obvious antitumor and protects the liver dirty effect.Poria slightly sweet flavor is put down, and enters the heart, lung, spleen channel.There is eliminating dampness and diuresis, invigorating the spleen and regulating the stomach, effect of mind tranquilizing and the heart calming.Can control dysuria, edema distension, phlegm retention cough with dyspnea, vomiting, malignant histocytosis, has loose bowels, seminal emission, stranguria with turbid discharge, palpitation with fear, forgetful disease such as grade.The diuretic of Poria, is reached by strong activating the spleen pulmonary function, different from the Chinese medicine of other direct diuretic.For diarrhea due to hypofunction of the spleen, leukorrhagia Poria can spleen invigorating, again can eliminating dampness by diuresis, and for having loose bowels caused by insufficiency of the spleen dysfunction of the spleen in transportation and transformation, leukorrhagia, application Poria has the effect of giving consideration to both the incidental and fundamental, the compatibilities such as normal and Radix Codonopsis, the Rhizoma Atractylodis Macrocephalae, Rhizoma Dioscoreae.Can be used as tonifying the lung spleen, control the adjuvant of the deficiency of vital energy.
JIAOSANXIAN (Fructus Crataegi, Fructus Hordei Germinatus, Massa Medicata Fermentata) is three taste medicines, i.e. Fructus Hordei Germinatus (parched to brown), Fructus Crataegi (parched to brown), Massa Medicata Fermentata (parched to brown).This three tastes medicine all has the stagnant function of good removing food stagnancyization, but has features different separately.Fructus Hordei Germinatus (parched to brown) has the effect of good digestible starch group food; Fructus Crataegi (parched to brown) is good at treating meat or greasy too much caused dyspepsia; Massa Medicata Fermentata (parched to brown) is then beneficial to digestion rice and flour food.Three medicines share, and can strengthen digestive function significantly.Therefore, three medicines often share and are called " JIAOSANXIAN (Fructus Crataegi, Fructus Hordei Germinatus, Massa Medicata Fermentata) " by doctor clinically.
Fructus Hordei Germinatus, forms through barley germination, and Fructus Hordei Germinatus is put micro-stir-fry extremely yellow in pot, spray clear water, taking-up is dried, and is Fructus Hordei Germinatus (parched to brown).Fructus Hordei Germinatus (parched to brown) has the stagnant merit of invigorating the spleen and regulating the stomach, soothing liver-QIization, is used for the treatment of that food stagnation does not disappear, the disease such as distension and fullness in the abdomen, inappetence, vomiting are had loose bowels.Modern study is thought, in Fructus Hordei Germinatus, rich in starch catabolic enzyme, conversion carbohydrase, esterified enzyme, vitamin B etc., have good digestion-aid effect.
Fructus Crataegi, section is dried, and put in pot large stir-fry of useing force and be degree to outer wrinkly face brown, inner yellowish-brown, spray clear water, taking-up is dried, and is Fructus Crataegi (parched to brown).Oral Fructus Crataegi can increase digestive enzyme, promotes decomposition and the digestion of fat, to because of eat meat or greasy too much caused by distension and fullness in the abdomen, belch, anorexia, stomachache, diarrhoea person, curative effect is especially good.In addition, modern medicines test shows, Fructus Crataegi has slow and lasting effect reduced blood pressure, and also can reduce cholesterol and triglyceride, atherosclerosis, but also can diastole coronary artery, increases myocardial contraction, to arrhythmia.Therefore, be conducive to preventing and treating hypertension, hyperlipidemia, arteriosclerosis and coronary heart disease.
Massa Medicata Fermentata is the processed goods through fermentation after whole wheat flour and other drug (Herba Artemisiae Annuae, Herba Xanthii, the buds such as Herba polygoni hydropiperis, Semen Armeniacae Amarum, Semen Phaseoli) mixing.Get Massa Medicata Fermentata to put in pot and fry to appearance be coke black, inner coke yellow, take out, sprinkling disappears water, cools, is Massa Medicata Fermentata (parched to brown).Massa Medicata Fermentata forms through fermentation, and the product of all fermentations have the digestant effect of strengthening the spleen and stomach, and therefore, bad, feeling of stuffiness in chest abdominal distention for the digestion caused by diet internal injury quite have effect.
Cortex Magnoliae Officinalis is bitter; Pungent; Warm in nature.Gui Jing: spleen channel; Stomach warp; Large intestine channel.Function: circulation of qi promoting removing food stagnancy; Dampness is except full; Against relievining asthma.Cure mainly: stagnation of QI due to dyspepsia; Abdominal distention constipation; Retention of dampness in middle-JIAO, gastral cavity painful abdominal mass is vomited and diarrhoea; Expectorant stops up QI rising in reverse order; Fullness in the chest is breathed with cough, and removing dampness by means of aromatics Chinese medicine, cures mainly: stagnation of QI due to dyspepsia; Abdominal distention constipation; Retention of dampness in middle-JIAO, gastral cavity painful abdominal mass is vomited and diarrhoea; Expectorant stops up QI rising in reverse order; Fullness in the chest is breathed with cough.Come from Shennong's Herbal.Bencao Jingshu ": Cortex Magnoliae Officinalis, main apoplexy, cold headache, cold and heat, the dead flesh person of QI and blood numbness, covers with wind and cold exopathogen, hinders and divide in sun, be then cold and heat headache; Wind and cold wets into space between skin and muscles, then QI and blood is coagulated and puckeryly formed numbness, very then numbness, and this medicine is pungent can eliminating stagnation, bitterly can bath wet, warm can cold-dispelling, therefore know main also." not Lu " main warming middle-JIAO, expectorant, therapeutic method to keep the adverse QI flowing downwards again, treats cholera, and stomachache distension, and cold in the stomach is inverse, vomits in the heart more than, lets out the vexed full person of dysentery, and what is is it possible that flatus is inverse stops up stagnant, and phlegm retention stays knot, caused by diet raw food.
The specific embodiment of the invention
Specific embodiment 1
The preparation of oral liquid of the present invention: get Radix Bupleuri 1500g, Rhizoma Cyperi 1500g, Radix Angelicae Sinensis 1500g, Poria 1500g, Semen Persicae 1500g, Rhizoma Chuanxiong 1500g, Cortex Magnoliae Officinalis 1500g, Radix Astragali 1500g, Folium Perillae 1500g, Rhizoma Polygonati 1500g, Fructus Rubi 1500g, Fructus Mori 1500g, JIAOSANXIAN (Fructus Crataegi, Fructus Hordei Germinatus, Massa Medicata Fermentata) 1500g, Fructus Ligustri Lucidi 1500g, Radix Salviae Miltiorrhizae 1500g, FLOS MUME 1500g, Radix Curcumae 1500g, Radix Polygalae 1500g, Radix Paeoniae Rubra 1500g, Radix Achyranthis Bidentatae 1500g.All raw material powders are broken into granule, dry, decontamination of winnowing with a dustpan, and to be then soaked in ethanol 24 hours.Heating extraction 2 times, each 1-2 hour, merge extractive liquid, remove supernatant after leaving standstill, then 100-120 order filters, then is the ultrafiltration post ultrafiltration of 5000-10000 through the molecular weight that dams, when ultrafiltrate concentrating under reduced pressure relative density is 80 DEG C 1.36 extractum, stand for standby use, becomes component 1.The medicinal residues of the crude drug crossed by above-mentioned ethanol extraction add 10 times of water gagings, heating and refluxing extraction 2 times, each 1 ~ 2 hour, are merged by 2 extracting solution and leave standstill; Above-mentioned two kinds of extracting solution are merged, decompression recycling ethanol to be concentrated into liquor strength be 0.6g crude drug/mL, after sucking filtration, when the relative density of filtrate is about 20 DEG C 1.08; Being concentrated into relative density is 1.20, and the extractum of temperature to 60 DEG C-70 DEG C, stand for standby use, becomes component 2.Merged by the extractum of component 1 and component 2, then put into concentrating under reduced pressure tank, being evaporated to relative density is 1.20, then takes out, and adding dextrin or Mel, to reconcile into oral liquid canned.
Specific embodiment 2
The preparation of oral liquid of the present invention:
Get Radix Bupleuri 1200g, Rhizoma Cyperi 1300g, Radix Angelicae Sinensis 1100g, Poria 1100g, Semen Persicae 1200g, Rhizoma Chuanxiong 1100g, Cortex Magnoliae Officinalis 1200g, Radix Astragali 1100g, Folium Perillae 1200g, Rhizoma Polygonati 1100g, Fructus Rubi 1200g, Fructus Mori 1300g, JIAOSANXIAN (Fructus Crataegi, Fructus Hordei Germinatus, Massa Medicata Fermentata) 1200g, Fructus Ligustri Lucidi 1200g, Radix Salviae Miltiorrhizae 1100g, FLOS MUME 1200g, Radix Curcumae 1200g, Radix Polygalae 1100g, Radix Paeoniae Rubra 1100g, Radix Achyranthis Bidentatae 1200g.All raw material powders are broken into granule, dry, decontamination of winnowing with a dustpan, to be then soaked in ethanol 24 hours.By soaked heating raw materials reflux, extract, 2 times, each 1 ~ 2 hour, 2 extracting solution are merged and leaves standstill, remove supernatant, merge extractive liquid, leaves standstill 24 hours, removes supernatant, when to put into thickener concentrating under reduced pressure relative density be 80 DEG C 1.36 extractum, stand for standby use, becomes component 1.The medicinal residues of the raw material crossed by above-mentioned ethanol extraction add 10 times of water gagings, then put into extraction pot heated and boiled 1 hour, and filter, filtrate is for subsequent use; Filtering residue adds water, and second time heating, boils 45 minutes, and filter, filtrate is for subsequent use; Filtering residue adds water again, heated and boiled half an hour third time, filters; Three filtrates be combined, by filtered through gauze, add 50-60% ethanol in residue, 60 DEG C-70 DEG C are continued lixiviate 2h, and every 10min stirs once, filtered through gauze, merge lixiviating solution, are condensed into pasty state, become component 2.Merged by the extractum of component 1 and component 2, then put into concentrating under reduced pressure tank, reclaim ethanol, being concentrated into relative density is 1.20, and the extractum of temperature to 60 DEG C-70 DEG C, then takes out, and adding dextrin or Mel, to reconcile into oral liquid canned.
Specific embodiment 3
The preparation of oral solutions of the present invention:
Get Radix Bupleuri 1300g, Rhizoma Cyperi 1300g, Radix Angelicae Sinensis 1100g, Poria 1100g, Semen Persicae 1200g, Rhizoma Chuanxiong 1300g, Cortex Magnoliae Officinalis 1200g, Radix Astragali 1300g, Folium Perillae 1100g, Rhizoma Polygonati 1200g, Fructus Rubi 1100g, Fructus Mori 1300g, JIAOSANXIAN (Fructus Crataegi, Fructus Hordei Germinatus, Massa Medicata Fermentata) 1200g, Fructus Ligustri Lucidi 1200g, Radix Salviae Miltiorrhizae 1100g, FLOS MUME 1200g, Radix Curcumae 1200g, Radix Polygalae 1300g, Radix Paeoniae Rubra 1100g, Radix Achyranthis Bidentatae 1200g.All raw material powders are broken into granule, dry, decontamination of winnowing with a dustpan, to be then soaked in ethanol 24 hours.Heating extraction 2 times, each 1-2 hour, merge extractive liquid, remove supernatant after leaving standstill, then 100-120 order filters, then is the ultrafiltration post ultrafiltration of 5000-10000 through the molecular weight that dams, when ultrafiltrate concentrating under reduced pressure relative density is 80 DEG C 1.36 extractum, stand for standby use, becomes component 1.The medicinal residues of the crude drug crossed by above-mentioned ethanol extraction add 10 times of water gagings, heating and refluxing extraction 2 times, each 1 ~ 2 hour, are merged by 2 extracting solution and leave standstill; Above-mentioned two kinds of extracting solution are merged, decompression recycling ethanol to be concentrated into liquor strength be 0.6g crude drug/mL, after sucking filtration, when the relative density of filtrate is about 20 DEG C 1.08; Being concentrated into relative density is 1.20, and the extractum of temperature to 60 DEG C-70 DEG C, stand for standby use, becomes component 2.By component 1 and component 2-in-1 and after insert in economic benefits and social benefits vacuum concentrator, when being concentrated into 90 DEG C, relative density is the concentrated solution of 1.05, sets to 0 ~ 5 DEG C of deepfreezes 24 hours; Cold preservation liquid is added the filter aid kieselguhr of 0.3%, filter, filtrate is inserted in economic benefits and social benefits vacuum concentrator again, is concentrated into every 1ml containing 1g crude drug amount; Unguentum after concentrated adds dextrin and is in harmonious proportion, and bottles after ultraviolet ray sterilization bactericidal.
Pharmacological toxicity is tested
One, skin irritation test
1, experimental technique
Depilatory is evenly coated by guinea pig back spinal column both sides, makes unhairing scope about 20 square centimeters.Clean depilatory returns cage to observe 24 hours, often organize Cavia porcellus and be coated with the present invention's (pill) 4,8 and 12g respectively, respectively containing crude drug 92mg, 184mg and 368mg, another group is coated with the every twice-daily of solvent 0.8ml, continuous one week, after experiment terminates, Cavia porcellus is put to death, the heart, liver, kidney and depilation skin do pathological examination.
2, result
Above-mentioned three groups of medication Cavia porcellus trunks depilation district, having no local skin has edema, hyperemia, erythema, petechia and ulcer.Medication group Cavia porcellus chroma of hair, ingest, the matched group no significant difference such as extremity are movable, histopathologic examination, the administration group heart, liver, kidney and depilation skin with contrast word more also no significant difference.
Result is pointed out, and the present invention, without local irritant effect, also has no general toxicity performance.Show invention formulation use safety.
Two, animal acute toxicity test research:
The present invention, through trial test, can not measure LD 50, therefore measures maximum dosage-feeding.Adopt rectal delivery, the maximum dosage-feeding on the one recording mice is 62.7g/kg (in medicated powder), be about 1567.5 times (people is in 60kg) intending clinical people's consumption, the maximum dosage-feeding 62.7g/kg (in medicated powder) on the one of rat, is about 1567.5 times that intend clinical people's consumption.The equal Continuous Observation of laboratory animal one week, its outward appearance sign, the mental status, diet, drinking-water, feces etc. are showed no obvious abnormalities.At the end of experiment, all healthy survival of animal, body weight increases.
Three, long-term toxicity test for animals research:
One, test material and method
(1) test medicine: the tablet that the embodiment of the present invention is made.
(2) laboratory animal, healthy rat Wistar, body weight 100-130g, 140 male and female half and half, by sex and body weight random packet, four groups, often organize 35.1, take test medicine for 2,3 groups, dosage is respectively 9.6/kg/d, 6.4/kg/d, 3.2/kg/d.4 groups contrast to the distilled water of respective volume amount, the equal gavage enteral administration of rat, often organize and be once used in conjunction 6 months, put to death half, and all death in 12 days is observed in remaining 1/2 drug withdrawal.
Two, test index
(1) general status comprises body weight, diet, emotion, movable energy.
(2) hemogram checking: red blood cell count(RBC), numeration of leukocyte, platelet count, hemogram etc., quantitative hemoglobin counts.
(3) biochemical analysis, serum albumin quantitatively, cholesterol, blood sugar quantitative.
(4) pathologic diagnosis: get half animal after experimental result and weigh, sacrificed by decapitation, gets blood, solution is treated others for earnest simultaneously, liver, kidney, lung, brain, spleen, gastrointestinal, bladder, adrenal gland do pathologic diagnosis.
Three, result of the test: show through rat chronic toxicity test, with the heavy dose of coloclysis of the present invention six months, increases the growth of rat, body weight, all has no side effect to brain, Liver and kidney function.Do not find that infringement changes to each histoorgan of rat, blood circulation, medication group compares no significant difference with matched group.Illustrate that medicine of the present invention has warming and recuperating the kidney-YANG, QI invigorating, enriches blood, strengthens the drug effects such as metabolism, avirulence.
Medicine and clinical experiment
Syndrome of qi stagnation and blood stasis refers to mechanism of qi retardance and hyperamization clots absorbing hinders the syndrome showed.Often because feelings will is unsuccessful, caused by sprain and contusion wound or cold-evil's internal resistance etc.Clinical manifestation fullness and distention in the chest and hypochondrium or walk to alter pain, irascible temperament, the lower mass in the abdomen of the side of body, twinge tenderness, enters Night Watch very, or dysmenorrhes, and dark menses, accompanies stasis of blood block, and purplish tongue is dark or have ecchymosis etc.
Gas is to essence to micro-living matter in human body, is the important substance basis of vital movement, have promote blood generation, operation, and the function such as the generation of body fluid, defeated cloth and excretion.The more difficult assurance of concept of the traditional Chinese medical science " gas ", but " gas " is material after all, has its material base just can complete its critical function.In order to the essence of Primary Study " gas " and the dependency of gaseous signal molecule, this experiment copies qi depression to blood stasis disease model, observe the situation of change of gaseous signal molecule NO in its model body, examine whether to there is dependency with " gas " in theory of Chinese medical science, the research for syndrome of blood stasis and Blood-Activating-and-Stasis-Removing medicine provides a new thinking.
1 materials and methods
1.1 reagent N O test kits (20111123), NOS test kit (20111123) (Bioengineering Research Institute is built up in Nanjing), Trizol (D9108A), RT-PCR kit (DRR019A), agarose (D601), Marker (D526A) primer (precious biological engineering (Dalian) company limited).
1.2 laboratory animals and the healthy wistar rat of grouping SPF level, male and female half and half, body weight 180g mono-200g, is divided into 4 groups at random, is respectively matched group, model group, low dose group of the present invention and high dose group.
1.3 duplicating models adopt the modeling of multifactor combined stimulation method.Stimulating factor comprises sound, optical, electrical, ice-water bath, constraint, folder tail, stimulates 2 every day, continues 5 Zhou Shiwen.
1.4 NO content in plasma measure after NO produces and transform rapidly nitrite (NO in vivo
2-) and nitrate (NO
3-), and NO
2-one is further converted to NO again
3-.Utilize nitrate reductase specifically by NO
3-reductive NO
2-, measure NO by the colour developing depth
2-one concentration level.
The operation of NO and NOS detection kit description is pressed in 1.5 hepatic tissue TNOS and iNOS determination of activity, measure NO synthase (TNOS), inducible NO-synthase (iNOS) is active, the active iNOS of structural type NO synthase (eNOS) activity=TNOS is active.
1.6RT-PCR method measures hepatic tissue eNOS gene expression reference literature and adopts Trizol reagent to extract total serum IgE, carries out reverse transcription synthesis cDNA, carry out pcr amplification as template according to Reverse Transcriptase kit description.Reaction condition eNOS, B-actin annealing temperature 65 DEG C.Employing gel image analyser scans, and measures the A of genes of interest and B-actin amplification, calculates the ratio of itself and B-actin, in table 1.
Table 1eNOS and actin gene primer sequence
1.7 common carotid artery eNOS immunohistochemical analysis common carotid artery paraffin section routine dewaxing aquations, endogenous peroxydase 15min eliminated by 3% hydrogen peroxide, microwave method antigen retrieval 10min, drip primary antibodie, 4 ~ C spends the night, and next day, order added two anti-and three to resist, hatch 30min for 37 DEG C respectively, DAB develops the color, haematoxylin redyeing, light Microscopic observation eNOS expression J in common carotid artery endotheliocyte.The painted grey decision-making of eNOS positive cell is measured by color pathological analytical system.Grey decision-making is less, illustrates painted darker, and reflection eNOS expression is more, carries out quantizing rear row statistical analysis with grey decision-making.
1.8 statistical data analysis represents with (± s), application SPSS 17.0 processes, and many group sample averages compare employing One-way ANOVA variance analysis, and compare between two between group, the neat person of variance checks by LSD method, and heterogeneity of variance person checks with Tamhane s12.
2 results
2.1 blood plasma and Enzyme assay in liver NO content and hepatic tissue are compared with matched group, in model group blood plasma and hepatic tissue, NO content obviously reduces (P < 0.01), and in low dose group blood plasma and hepatic tissue, NO content is apparently higher than model group (P < 0.05).Compared with matched group, model group TNOS, cNOS activity all obviously reduce (P < 0.01), and low dose group TNOS, cNOS are active in model group (P < 0.05), in table 2.
NO content in table 2 syndrome of qi stagnation and blood stasis rat plasma and liver
And the change of enzymatic activity (n=8, x ± s)
Note: compare .**P < 0.01 with matched group; Compare with model group, Δ p < 0.01, Δ Δ p < 0.05.
3 discuss
Nitric oxide is the more active lipophilic small molecule compound of a kind of chemical property, finally generated under NOS effect by L-arginine in vivo, can continue produce and through biomembrane free diffusing, there is vasodilator, the physiological function such as reduce blood pressure, and plays an important role in cardiovascular system, immune system and nervous system.Apply existing more than 100 year of nitro class vasodilator medicine clinically, along with going deep into of research, people understand its mechanism of action, are actually as NO donor.The drug-induced vasorelaxation action of nitro class vasodilator directly depends on the growing amount of NO, and amount effect relationship, be played a role by gaseous signal molecule to syndrome of blood stasis medicative nitro class vasodilator medicine essence.
The formation of syndrome of qi stagnation and blood stasis is a veryer long process, relevant with factors such as emotion, diet, age, environment, diseases.The traditional Chinese medical science think the activity of spiritual feelings will be with internal organs change the vital essence blood of raw and storage for material base, and liver controlling conveyance and dispersion is anger in will, and anger take blood stored in the liver as material base, liver stored blood, regulating blood flow amount and prevent the hemorrhage liver catharsis mechanism of qi that depends on to be achieved.In this test, rat causes feelings will to change through multifactor combined stimulation, is in rage state for a long time, thus establishes qi depression to blood stasis model.Experimental result display syndrome of qi stagnation and blood stasis NO content and NOS expression obviously reduce (P < 0.01), after giving promoting flow of QI and blood medicine, NO content and NOS expression significance increase (P < 0.01), the two variation tendency is consistent, this also demonstrates NO vasodilator function, and research discloses circulation of qi promoting blood circulation promoting medicine can raise NO/NOS system.There are some researches show Endothelial dysfunction after body tissue ischemia-reperfusion; histiocyte can form irreversible damage; after tissue ischemia, eNOS activity, eNOS gene expression dose and NO content all obviously reduce; after perfusion recovers in ischemic tissue; eNOS activity, eNOS gene expression dose and NO content are lower than basic value; recover perfusion 2h, These parameters is close to basic value, and this is a process of body self-protection.In theory of Chinese medical science, " gas " is the life thing extremely micro-to essence be present in human body, be the important substance basis of vital movement, there is very strong vigor, the generation of blood, operation can be promoted, and the effect such as the generation of body fluid, defeated cloth and excretion, there is living matter and physiological function double attribute.The traditional Chinese medical science about the discussion of " the capable then blood of gas, the stagnation of QI is blood stasis then for qi being the governor of blood, blood being the material foundation of QI ", the substantial connection reflecting the interaction of QI and blood in physiological and pathological and mutually cause a disease.The essence of further further investigated gas and qi-blood relationship, can provide new approach for treatment syndrome of blood stasis, have great importance to the research of combination of Chinese and Western medicine syndrome of blood stasis.
Clinical trial:
Dysmenorrhes is commonly encountered diseases, affects its physically and mentally healthy and study to a certain extent.Western medical treatment mainly adopts non-steroidal anti-inflammatory drugs and contraceptive treatment, belongs to anti symptom treatment more, though get effect fast, often recur, and side effect is larger after drug withdrawal.Chinese traditional treatment dysmenorrhea accounts for clinically and has great advantage, evident in efficacy and side effect is little.This research purpose probes into the common TCM Syndrome Type of the dysmenorrhea that qi depression to blood stasis causes and effective Therapeutic Method.
1 data and method
1.1 physical data
My 200, Out-patient Department gynecological of random selecting, the age is in (17.35 ± 0.27) ~ (21.74 ± 0.12) year.Rejecting data is not enough, and getting rid of pelvic cavity has positive discovery, finally filters out eligible person totally 160 people.Wherein dysmenorrheal caused by qi stagnation and blood stasis totally 80 examples.Be divided into two groups, treatment group of the present invention and matched group are without significant difference.
1.2 deliberated index
1. pain degree criteria for classification adopts visual analogue scales (VAS scoring), can be divided into 3 degree by pain degree: slight: 1 ~ 3 point; Moderate: 4 ~ 6 points; Severe: 7 ~ 10 points.2. Standards of Chinese Medical Syndrome Differentiation is with reference to " Gynecology of Chinese Medicine dysmenorrhea " typing.3. symptom integral: with reference to the standards of grading of " new Chinese medicine guideline of clinical investigations ", dysmenorrhea symptom integral >=14 point severe; Dysmenorrhea symptom integral 8 ~ 13.5 points of moderates: dysmenorrhea symptom integral < 8 points is slight.4. clinical efficacy is cured: pain degree returns to 0 point, other transference cure, follows up a case by regular visits to the no recurrence of 3 menstrual cycle; Effective: integration is reduced to 1/2 of the front integration for the treatment of, and symptom takes a turn for the better, and refuses to obey that analgesic can adhere to work; Effective: integration is reduced to 1/2 ~ 3/4 of the front integration for the treatment of, and symptom takes a turn for the better, and taking analgesic can adhere to work; Invalid: stomachache and other symptom are without change.5. lab testing: empty stomach extracting vein blood 4ml detection prostaglandin in morning (F2a) in menstrual onset 24 ~ 48h.
1.3 method
The above academic title of traditional Chinese medical science attending doctor, carries out pattern of syndrome judgement to MethodsThe cases enrolled by above standard.By qi stagnation and blood stasis type patient 80 people maximum for pattern of syndrome, be divided into 2 groups, often organize 40 people.Treatment group adopts the present invention to treat.Fang Yong: Radix Bupleuri 15g, Rhizoma Cyperi 12g, Radix Angelicae Sinensis 12g, Poria 12g, Semen Persicae 13g, Rhizoma Chuanxiong 13g, Cortex Magnoliae Officinalis 12g, Radix Astragali 13g, Folium Perillae 13g, Rhizoma Polygonati 12g, Fructus Rubi 11g, Fructus Mori 12g, JIAOSANXIAN (Fructus Crataegi, Fructus Hordei Germinatus, Massa Medicata Fermentata) 13g, Fructus Ligustri Lucidi 12g, Radix Salviae Miltiorrhizae 13g, FLOS MUME 12g, Radix Curcumae 12g, Radix Polygalae 12g, Radix Paeoniae Rubra 12g, Radix Achyranthis Bidentatae 11g.Contrast groups decoction for removing blood stasis is treated.
Treatment in 1 week before menstrual onset, later monthly treatment in premenstrual 1 week, treats, is for 9 times 1 course for the treatment of, treat statistical correlation data after 1 course for the treatment of for continuous 3 months.
1.4 statistical procedures
Data information adopts S to represent, t and X 2 test, and P < 0.05 has significant for difference.
2 results
Treat after 3 months, 80 routine patients symptomatic's integrations, pain scores obviously reduce before all comparatively treating.In table 1.The evaluation for the treatment of clinical efficacy, treatment group cures 29 examples, effective 10 examples, invalid 1 example; Contrast groups, healing is 21 examples, effective 10 examples, and invalid is 9 examples.The state of an illness be light, in, between severe patient, effective percentage is poor apart from without significant.
Compare (X ± S) before and after the routine patient's indices treatment of table 180
Project | N | Before treatment | After treatment |
Symptom integral | 80 | 10.35±2.36 | 6.87±2.22* |
Pain scores | 80 | 7.21±2.34 | 4.24±1.98* |
PGF2a(mmol/l) | 80 | 128.56±41.85 | 88.54±33.78** |
Note; * P < is compared O.05, * * P < 0.01 with before treatment.
3 discuss
Dysmenorrhea is that endometrium synthesis and release PGF2a increase, and causes hysterospasm shrink and produce pain.Women be in go to school, take an advanced study, choose a job, marriage, many-sided unstable factor such as emotion the emotion changeable phase, abnormal emotion-thought and affect zang-fu organs qi movement, cause QI and blood transporting disorderly, impact punching is appointed and causes pain, " stagnation of QI and blood may bring about pain ".Patient is anxiety-depression because of long pain, therefore the normal life of impact, lack human communication etc., this has increased the weight of again depressive anxiety state further, has occurred the disease due to stagnation of QI-blood, the vicious cycle of stagnation of QI-blood due to disease.Woman is congenital with liver, and the disgruntled thing of normal susceptible will causes functional activity of QI being not smooth, qi being the governor of blood, and the capable then blood of gas, the stagnation of QI is blood stasis then, and married woman's qi stagnation and blood stasis type proportion is maximum.
The author carries out treatment by the method to the court qi stagnation and blood stasis type primary dysmenorrhea women and achieves good curative effect, thinks that this method is worth at clinical further genralrlization.
Specific embodiment 1: Lee, female, 29 years old, white collar, abdominal pain during menstruation companion did not practise contraception unpregnancy more than 2 years.Dysmenorrhea generally at premenstrual 1 ~ 2 day to menstruation the 2nd day obviously, treats that menstrual blood volume is gradually many, pain relief after having large clot to discharge.Menstruation 30 days one tide, measure medium, color is purple, have clot, with distention and pain of breast before menstruation, there is purple gas on red tongue limit, wiry and frequent pulse.Tcm diagnosis is dysmenorrhea, and card belongs to stagnation of liver-QI blood stasis.Control with dispersing the stagnated live-QI to relieve the stagnation of QI, blood circulation promoting and blood stasis dispelling, side's Xuefu Zhuyu Decoction, but always intermittent, DeGrain.Use oral liquid of the present invention instead, Fang Yong: Radix Bupleuri 12g, Rhizoma Cyperi 12g, Radix Angelicae Sinensis 12g, Poria 12g, Semen Persicae 13g, Rhizoma Chuanxiong 12g, Cortex Magnoliae Officinalis 12g, Radix Astragali 13g, Folium Perillae 13g, Rhizoma Polygonati 12g, Fructus Rubi 11g, Fructus Mori 12g, JIAOSANXIAN (Fructus Crataegi, Fructus Hordei Germinatus, Massa Medicata Fermentata) 13g, Fructus Ligustri Lucidi 12g, Radix Salviae Miltiorrhizae 13g, FLOS MUME 12g, Radix Curcumae 12g, Radix Polygalae 12g, Radix Paeoniae Rubra 12g, Radix Achyranthis Bidentatae 11g.Make oral liquid, every day 2 bottles.Advise premenstrual 1 week clothes, serve on 7 days.Patient's continuous 3 cycles.Within premenstrual 1 week, take medicine, symptom is obviously alleviated, and successful pregnancies.
Specific embodiment 2: the Qin, female, 34 years old.The first visit time: on February 15th, 2012.Main suit: more than 10 years of menstruation menoxenia.History of present illness: menstrual cycle 20-25 days, menstrual period general 4-5 days, the last menstrual period time: on February 15th, 2009.This time menstruation shifts to an earlier date 5 days, and have clot, in 5 days menstrual period, leucorrhea amount holds the blood streak under the arm more.Lumbago between menstrual period, two lower limb cold type of pain.Bilateral cheekbone portion acne, premenstruum increases the weight of.Tired weak, anorexia, peace of sleeping, two just adjust.The micro-Huang of light red tongue tongue, stringy and thready pulse.Dialectical: depression of liver-QI, deficiency of spleen-YANG and kidneyYANG.Method for the treatment of: dispersing the stagnated live-QI to relieve the stagnation of QI, invigorate the spleen and warm the kidney.Fang Yong: Radix Bupleuri 12g, Rhizoma Cyperi 12g, Radix Angelicae Sinensis 12g, Poria 12g, Semen Persicae 13g, Rhizoma Chuanxiong 12g, Cortex Magnoliae Officinalis 12g, Radix Astragali 13g, Folium Perillae 13g, Rhizoma Polygonati 12g, Fructus Rubi 11g, Fructus Mori 12g, JIAOSANXIAN (Fructus Crataegi, Fructus Hordei Germinatus, Massa Medicata Fermentata) 13g, Fructus Ligustri Lucidi 12g, Radix Salviae Miltiorrhizae 13g, FLOS MUME 12g, Radix Curcumae 12g, Radix Polygalae 12g, Radix Paeoniae Rubra 12g, Radix Achyranthis Bidentatae 11g.Make oral liquid, every day 2 bottles.Two examine the time: on March 5th, 2012.Behind patient's readme clothes top, symptom alleviates.Existing disease stool is shapeless, day a line.Lassitude loin and legs's pain, fear of cold.The micro-Huang of light red tongue tongue is greasy, and Sublingual is livid purple, stringy and thready pulse.Continue to take 1 week.Three examine the time: on March 12nd, 2012.Behind patient's readme clothes top, symptom alleviates.The existing micro-Huang of light red tongue tongue, stringy and thready pulse.Further consultation after serveing on March, private prosecution disappears through row or postmenstrual abdominal pain, and follow-up study 3 months, has no recurrence.
Claims (10)
1. treat the health care oral liquid of qi depression to blood stasis for one kind, it is characterized in that, the parts by weight of the raw material of described oral liquid comprise: Radix Bupleuri 10 ~ 20 parts, Rhizoma Cyperi 10 ~ 20 parts, Radix Angelicae Sinensis 10 ~ 20 parts, 10 ~ 20 parts, Poria, 10 ~ 20 parts, Semen Persicae, Rhizoma Chuanxiong 10 ~ 20 parts, Cortex Magnoliae Officinalis 10 ~ 20 parts, the Radix Astragali 10 ~ 20 parts, Folium Perillae 10 ~ 20 parts, Rhizoma Polygonati 10 ~ 20 parts, Fructus Rubi 10 ~ 20 parts, Fructus Mori 10 ~ 20 parts, JIAOSANXIAN (Fructus Crataegi, Fructus Hordei Germinatus, Massa Medicata Fermentata) 10 ~ 20 parts, Fructus Ligustri Lucidi 10 ~ 20 parts, Radix Salviae Miltiorrhizae 10 ~ 20 parts, FLOS MUME 10 ~ 20 parts, Radix Curcumae 10 ~ 20 parts, Radix Polygalae 10 ~ 20 parts, Radix Paeoniae Rubra 10 ~ 20 parts, Radix Achyranthis Bidentatae 10 ~ 20 parts.
2. treat the health care oral liquid of qi depression to blood stasis according to claim 1, it is characterized in that, the parts by weight of the raw material of described oral liquid comprise: Radix Bupleuri 10 ~ 15 parts, Rhizoma Cyperi 10 ~ 15 parts, Radix Angelicae Sinensis 10 ~ 15 parts, 10 ~ 15 parts, Poria, 10 ~ 15 parts, Semen Persicae, Rhizoma Chuanxiong 10 ~ 15 parts, Cortex Magnoliae Officinalis 10 ~ 15 parts, the Radix Astragali 10 ~ 15 parts, Folium Perillae 10 ~ 15 parts, Rhizoma Polygonati 10 ~ 15 parts, Fructus Rubi 10 ~ 20 parts, Fructus Mori 10 ~ 20 parts, JIAOSANXIAN (Fructus Crataegi, Fructus Hordei Germinatus, Massa Medicata Fermentata) 10 ~ 20 parts, Fructus Ligustri Lucidi 10 ~ 20 parts, Radix Salviae Miltiorrhizae 10 ~ 20 parts, FLOS MUME 10 ~ 20 parts, Radix Curcumae 10 ~ 20 parts, Radix Polygalae 10 ~ 20 parts, Radix Paeoniae Rubra 10 ~ 20 parts, Radix Achyranthis Bidentatae 10 ~ 20 parts.
3. treat the health care oral liquid of qi depression to blood stasis according to claim 1, it is characterized in that, the parts by weight of the raw material of described oral liquid comprise: Radix Bupleuri 10 ~ 20 parts, Rhizoma Cyperi 10 ~ 20 parts, Radix Angelicae Sinensis 10 ~ 20 parts, 10 ~ 20 parts, Poria, 10 ~ 20 parts, Semen Persicae, Rhizoma Chuanxiong 10 ~ 20 parts, Cortex Magnoliae Officinalis 10 ~ 20 parts, the Radix Astragali 10 ~ 20 parts, Folium Perillae 10 ~ 20 parts, Rhizoma Polygonati 10 ~ 20 parts, Fructus Rubi 10 ~ 15 parts, Fructus Mori 10 ~ 15 parts, JIAOSANXIAN (Fructus Crataegi, Fructus Hordei Germinatus, Massa Medicata Fermentata) 10 ~ 15 parts, Fructus Ligustri Lucidi 10 ~ 15 parts, Radix Salviae Miltiorrhizae 10 ~ 15 parts, FLOS MUME 10 ~ 15 parts, Radix Curcumae 10 ~ 15 parts, Radix Polygalae 10 ~ 15 parts, Radix Paeoniae Rubra 10 ~ 15 parts, Radix Achyranthis Bidentatae 10 ~ 15 parts.
4. according to any one of claims 1 to 3, treat a preparation method for the health care oral liquid of qi depression to blood stasis, it is characterized in that, the preparation process of described oral liquid comprises:
A, all raw material components to be soaked in ethanol 24 hours;
B, again by crude drug heat extract 2 times, become paste, be component 1;
C, medicinal residues add water and extract, as component 2;
D, above-mentioned two kinds of components to be merged, be condensed into pasty state add Mel or dextrin be in harmonious proportion after canned.
5. treat the preparation method of the health care oral liquid of qi depression to blood stasis according to claim 4, it is characterized in that, in described step a, all raw material powders are broken into granule, dry, decontamination of winnowing with a dustpan, to be then soaked in ethanol 24 hours.
6. treat the preparation method of the health care oral liquid of qi depression to blood stasis according to claim 4, it is characterized in that, in described step b, by soaked heating raw materials reflux, extract, 2 times, each 1 ~ 2 hour, 2 extracting solution are merged and leaves standstill, remove supernatant, merge extractive liquid, leave standstill 24 hours, remove supernatant, when to put into thickener concentrating under reduced pressure relative density be 80 DEG C 1.36 extractum, stand for standby use, becomes component 1.
7. treat the preparation method of the health care oral liquid of qi depression to blood stasis according to claim 4, it is characterized in that, in described step c, medicinal residues are added 10 times of water gagings, then put into extraction pot heated and boiled 1 hour, filter, filtrate is for subsequent use; Filtering residue adds water, and second time heating, boils 45 minutes, and filter, filtrate is for subsequent use; Filtering residue adds water again, heated and boiled half an hour third time, filters; Three filtrates be combined, by filtered through gauze, add 50-60% ethanol in residue, 60 DEG C-70 DEG C are continued lixiviate 2h, and every 10min stirs once, filtered through gauze, merge lixiviating solution, are condensed into pasty state, become component 2.
8. treat the preparation method of the health care oral liquid of qi depression to blood stasis according to claim 4, it is characterized in that, in described steps d, by component 1 and component also 2-in-1, then put into concentrating under reduced pressure tank, reclaim ethanol, when being concentrated into 90 DEG C, relative density is the extractum of 1.05, be concentrated into every 1ml containing 1g crude drug amount, then add Mel or dextrin mediation bottling.
9. according to any one of claims 1 to 3, treat a preparation method for the health care oral liquid of qi depression to blood stasis, it is characterized in that, the preparation method of described oral liquid can also be following steps:
All raw materials are put into 10 times amount ethanol to soak more than 24 hours, heating and refluxing extraction 2 times, each 1 ~ 2 hour, 2 extracting solution are merged and leaves standstill, remove supernatant, merge extractive liquid, be the ultrafiltration post ultrafiltration of 5000-10000 again through the molecular weight that dams, when ultrafiltrate concentrating under reduced pressure relative density is 80 DEG C 1.36 extractum, heating be concentrated into paste, stand for standby use, becomes component 1; The medicinal residues that above-mentioned ethanol extraction is crossed are added 10 times of water gaging heating and refluxing extraction 2 times, each 1 ~ 2 hour, 2 extracting solution are merged and leaves standstill, remove supernatant, merge extractive liquid, then be the ultrafiltration post ultrafiltration of 5000-10000 through the molecular weight that dams, when ultrafiltrate concentrating under reduced pressure relative density is 80 DEG C 1.36 extractum, heating is concentrated into paste, stand for standby use, becomes component 2; Merged by above-mentioned two kinds of extracting solution, reducing pressure after reclaiming ethanol, it is concentrated to put into concentrator, then adds dextrin and is in harmonious proportion, pack after ultraviolet radiation for sterilizing and disinfecting.
10. the preparation method of the Semen Cuscutae oral liquid of the kidney invigorating and essence nourishing according to claim 9, it is characterized in that: in above-mentioned steps, two kinds of extracting solution are merged, reclaim decompression after ethanol put into concentrator concentrated time, when being concentrated into 90 DEG C, relative density is the concentrated solution of 1.05, sets to 0 ~ 5 DEG C of deepfreezes 24 hours; Cold preservation liquid is added the filter aid kieselguhr of 0.3%, filter, filtrate is inserted in economic benefits and social benefits vacuum concentrator again, is concentrated into every 1ml containing 1g crude drug amount.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410665602.9A CN104352983A (en) | 2014-11-20 | 2014-11-20 | Health oral liquid for treatment of qi-stagnancy and blood stasis and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410665602.9A CN104352983A (en) | 2014-11-20 | 2014-11-20 | Health oral liquid for treatment of qi-stagnancy and blood stasis and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104352983A true CN104352983A (en) | 2015-02-18 |
Family
ID=52520356
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410665602.9A Pending CN104352983A (en) | 2014-11-20 | 2014-11-20 | Health oral liquid for treatment of qi-stagnancy and blood stasis and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104352983A (en) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1092307A (en) * | 1993-03-15 | 1994-09-21 | 东风汽车公司 | Removing blood stasis in the chest Chinese medicine |
CN1476849A (en) * | 2002-08-21 | 2004-02-25 | 韩海龙 | Medicine composition for promoting blood circulation and removing stasis |
CN101703742A (en) * | 2009-12-08 | 2010-05-12 | 侯茹 | Preparation method of granules for treating acne caused by qi deficiency causing blood stasis and phlegm-heat stagnation |
CN101711849A (en) * | 2009-10-26 | 2010-05-26 | 泰一和浦(北京)中医药研究院有限公司 | Traditional Chinese medicine composition for treating symptoms of qi stasis, blood stasis, myoma and cyst and preparation method |
CN102949677A (en) * | 2012-12-03 | 2013-03-06 | 刘华 | Liver-soothing and stagnation-relieving particles and preparation method thereof |
CN103830682A (en) * | 2014-03-21 | 2014-06-04 | 赵世明 | Traditional Chinese medicine composition for treating liver depression and blood stasis syndromes |
-
2014
- 2014-11-20 CN CN201410665602.9A patent/CN104352983A/en active Pending
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1092307A (en) * | 1993-03-15 | 1994-09-21 | 东风汽车公司 | Removing blood stasis in the chest Chinese medicine |
CN1476849A (en) * | 2002-08-21 | 2004-02-25 | 韩海龙 | Medicine composition for promoting blood circulation and removing stasis |
CN101711849A (en) * | 2009-10-26 | 2010-05-26 | 泰一和浦(北京)中医药研究院有限公司 | Traditional Chinese medicine composition for treating symptoms of qi stasis, blood stasis, myoma and cyst and preparation method |
CN101703742A (en) * | 2009-12-08 | 2010-05-12 | 侯茹 | Preparation method of granules for treating acne caused by qi deficiency causing blood stasis and phlegm-heat stagnation |
CN102949677A (en) * | 2012-12-03 | 2013-03-06 | 刘华 | Liver-soothing and stagnation-relieving particles and preparation method thereof |
CN103830682A (en) * | 2014-03-21 | 2014-06-04 | 赵世明 | Traditional Chinese medicine composition for treating liver depression and blood stasis syndromes |
Non-Patent Citations (4)
Title |
---|
冠心病气滞血瘀证的研究进展;盛炜等;《中医药导报》;20101231;第16卷(第12期);102-104 * |
吕雄: "邱健行气滞血瘀理论及在血症中应用经验", 《江西中医药》 * |
盛炜等: "冠心病气滞血瘀证的研究进展", 《中医药导报》 * |
邱健行气滞血瘀理论及在血症中应用经验;吕雄;《江西中医药》;20001031;第31卷(第5期);7-9 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101322830B (en) | Medicament for treating postpartum depression and preparation method thereof | |
CN102784295B (en) | Health-care preparation formula for improving female climacteric syndrome and preparation method of same | |
CN103719492B (en) | A kind of gynostemma pentaphylla protecting and nourishing liver health protection tea and preparation method thereof | |
CN104146261B (en) | Traditional Chinese medicine health care product of a kind of Woman climacteric and preparation method thereof | |
CN103041264B (en) | Kudzuvine root brain-boosting and intelligence-boosting oral solution with function of preventing vascular dementia and preparation method thereof | |
CN103751709A (en) | Traditional Chinese medicinal composition for treating chloasma and preparation method thereof | |
CN103735835B (en) | A kind of Chinese medicine preparation for the treatment of young person with greying hair and preparation method thereof | |
CN102755596B (en) | Traditional Chinese medicine for treating phlegm-dampness hyperplasia of mammary glands and preparation method thereof | |
CN103751466B (en) | A kind of Chinese medicine preparation for the treatment of alopecia seborrheica and preparation method thereof | |
CN103751707A (en) | Burdock oral liquid for beautifying and removing freckles and preparation method thereof | |
CN102058715B (en) | Chinese medicine preparation for treating chronic prostatitis and preparation method thereof | |
CN103638250B (en) | One treats prosopoplegic Chinese medicine preparation and preparation method thereof | |
CN104958607A (en) | Traditional Chinese medicine composition for treating burning mouth syndromes of climacteric women and preparation method thereof | |
CN103749824B (en) | A kind of Herb Gynostemmae Pentaphylli blood sugar lowering blood pressure depressing health tea and preparation method thereof | |
CN102000164B (en) | Traditional Chinese medicine composition for treating psoriasis and preparation method thereof | |
CN104474500A (en) | Traditional Chinese medicine health product capable of enriching blood and regulating menstruation and preparation method of traditional Chinese medicine health product | |
CN104857288B (en) | Treat the Chinese medicine preparation and preparation method thereof of white hair | |
CN105497816A (en) | Traditional Chinese medicine preparation for treating atherosclerosis and preparation method thereof | |
CN105394282A (en) | Radix puerariae health tea capable of reducing blood pressure, blood sugar and blood lipid | |
CN104432386B (en) | A kind ofly prevent and treat soreness and weakness of waist and knees, parasitic loranthus oral liquid that muscles and bones is unable and preparation method thereof | |
CN104524479B (en) | A kind of Chinese medicine composition for treating premenstrual syndrome and preparation method thereof | |
CN105663700A (en) | Wrinkle resistance and beauty treatment cream making method and beauty treatment cream thereof | |
CN105616984A (en) | Crinkle-removing beauty cream containing herba leonurus and preparation method thereof | |
CN105362663A (en) | Traditional Chinese medicine preparation for treating juvenile poliosis | |
CN104352983A (en) | Health oral liquid for treatment of qi-stagnancy and blood stasis and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150218 |